GOPRO, INC., 10-Q filed on 5/5/2022
Quarterly Report
v3.22.1
Cover - shares
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
May 02, 2022
Class of Stock [Line Items]      
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 77-0629474    
Entity Address, Address Line One 3025 Clearview Way    
Entity Address, City or Town San Mateo,    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94402    
Title of 12(b) Security Class A common stock, $0.0001 par value    
Trading Symbol GPRO    
Entity Registrant Name GOPRO, INC.    
City Area Code (650)    
Local Phone Number 332-7600    
Entity Central Index Key 0001500435    
Entity Filer Category Large Accelerated Filer    
Document Type 10-Q    
Document Period End Date Mar. 31, 2022    
Document Transition Report false    
Entity File Number 001-36514    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus Q1    
Amendment Flag false    
Entity Emerging Growth Company false    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Shell Company false    
Security Exchange Name NASDAQ    
Entity Small Business false    
Current Fiscal Year End Date   --12-31  
Document Quarterly Report true    
Common Class A [Member]      
Class of Stock [Line Items]      
Entity Common Stock, Shares Outstanding     131,016,229
Common Class B [Member]      
Class of Stock [Line Items]      
Entity Common Stock, Shares Outstanding     26,258,546
v3.22.1
Audit Information
 3 Months Ended
Mar. 31, 2022
Audit Information [Abstract]  
Auditor Name PricewaterhouseCoopers LLP
Auditor Location San Jose, California
Auditor Firm ID 238
v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Current assets:      
Cash and cash equivalents $ 305,319,000   $ 401,087,000
Marketable securities 144,616,000   137,830,000
Accounts receivable, net 70,574,000   114,221,000
Inventory 119,396,000   86,409,000
Prepaid expenses and other current assets 26,869,000   42,311,000
Total current assets 666,774,000   781,858,000
Property and equipment, net 17,294,000   19,003,000
Operating Lease, Right-of-Use Asset 25,642,000   27,320,000
Goodwill 146,459,000   146,459,000
Other long-term assets 289,772,000   285,239,000
Total assets 1,145,941,000   1,259,879,000
Current liabilities:      
Accounts payable 82,925,000   171,545,000
Accrued expenses and other current liabilities 96,591,000   128,572,000
Short-term operating lease liabilities 9,859,000   9,819,000
Deferred revenue 43,914,000   42,505,000
Short-term Bank Loans and Notes Payable 124,963,000   122,391,000
Total current liabilities 358,252,000   474,832,000
Long-term taxes payable 7,790,000   7,319,000
Long-term debt 140,304,000   111,289,000
Long-term operating lease liabilities 40,203,000   43,025,000
Other long-term liabilities 6,606,000 $ 7,300,000 7,500,000
Total liabilities 553,155,000   643,965,000
Commitments, contingencies and guarantees  
Stockholders’ equity:      
Preferred Stock, Value, Outstanding 0   0
Common Stocks, Including Additional Paid in Capital 935,674,000 78,200,000 1,008,872,000
Treasury Stock, Value (123,613,000)   (113,613,000)
Accumulated deficit (219,275,000) 47,100,000 (279,345,000)
Total stockholders’ equity 592,786,000   615,914,000
Total liabilities and stockholders’ equity $ 1,145,941,000   $ 1,259,879,000
Preferred Stock, par value (usd per share) $ 0.0001    
Preferred Stock, Shares Authorized (shares) 5,000,000    
Preferred Stock, par value (usd per share) $ 0.0001    
Preferred Stock, Shares Authorized (shares) 5,000,000    
Common stock, par value (in dollars per share) $ 0.0001   $ 0.0001
Treasury Stock, Value $ 123,613,000   $ 113,613,000
Common Stocks, Including Additional Paid in Capital 935,674,000 78,200,000 1,008,872,000
Preferred Stock, Value, Outstanding $ 0   $ 0
Treasury Stock, Shares (shares) 11,830,000   10,710,000
Restricted Cash $ 0   $ 0
Cash and cash equivalents 305,319,000   401,087,000
Marketable securities 144,616,000   137,830,000
Accounts receivable, net 70,574,000   114,221,000
Inventory 119,396,000   86,409,000
Prepaid expenses and other current assets 26,869,000   42,311,000
Property and equipment, net 17,294,000   19,003,000
Operating Lease, Right-of-Use Asset 25,642,000   27,320,000
Goodwill 146,459,000   146,459,000
Other long-term assets 289,772,000   285,239,000
Accounts payable 82,925,000   171,545,000
Accrued expenses and other current liabilities 96,591,000   128,572,000
Short-term operating lease liabilities 9,859,000   9,819,000
Deferred revenue 43,914,000   42,505,000
Short-term Bank Loans and Notes Payable 124,963,000   122,391,000
Long-term taxes payable 7,790,000   7,319,000
Long-term debt 140,304,000   111,289,000
Long-term operating lease liabilities 40,203,000   43,025,000
Other long-term liabilities 6,606,000 7,300,000 7,500,000
Accumulated deficit $ (219,275,000) $ 47,100,000 $ (279,345,000)
Common stock, par value (in dollars per share) $ 0.0001   $ 0.0001
Treasury Stock, Shares (shares) 11,830,000   10,710,000
Common Class A [Member]      
Common stock outstanding (shares) 130,787,000   129,815,000
Common Stock, Shares Authorized (shares) 500,000,000   500,000,000
Common Stock, Shares, Issued 130,787,000   129,815,000
Common Stock, Shares Authorized (shares) 500,000,000   500,000,000
Common Stock, Shares, Issued 130,787,000   129,815,000
Common Class B [Member]      
Common stock outstanding (shares) 26,458,000   26,659,000
Common Stock, Shares Authorized (shares) 150,000,000   150,000,000
Common Stock, Shares, Issued 26,458,000   26,659,000
Common Stock, Shares Authorized (shares) 150,000,000   150,000,000
Common Stock, Shares, Issued 26,458,000   26,659,000
v3.22.1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 31, 2022
Mar. 31, 2021
Preferred Stock, par value (usd per share) $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized (shares) 5,000,000 5,000,000
Preferred Stock, Shares Issued (shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001  
Treasury Stock, Shares (shares) 11,830,000  
Common Class A [Member]    
Common Stock, Shares Authorized (shares) 500,000,000  
Common Stock, Shares, Issued 130,787,000  
Common stock outstanding (shares) 130,787,000  
Common Class B [Member]    
Common Stock, Shares Authorized (shares) 150,000,000  
Common Stock, Shares, Issued 26,458,000  
Common stock outstanding (shares) 26,458,000  
v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 216,705 $ 203,680
Cost of revenue 126,229 124,984
Gross profit 90,476 78,696
Operating expenses:    
Research and development 31,598 32,430
Sales and marketing 35,373 35,790
General and administrative 15,343 13,988
Total operating expenses 82,314 82,208
Operating income (loss) 8,162 (3,512)
Interest expense (2,209) (5,880)
Other income (expense), net (319)  
Other income (expense), net   443
Total other expense, net (2,528) (5,437)
Income (loss) before income taxes 5,634 (8,949)
Income tax expense (benefit) (51) 1,219
Net income (loss) $ 5,685 $ (10,168)
Earnings Per Share, Basic $ 0.04 $ (0.07)
Earnings Per Share, Diluted $ 0.04 $ (0.07)
Weighted Average Number of Shares Outstanding, Basic 156,864 152,181
Weighted Average Number of Shares Outstanding, Diluted 188,737 152,181
v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Operating activities:        
Net income (loss) $ 5,685,000   $ (10,168,000)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:        
Depreciation and amortization 2,302,000   3,534,000  
Non-cash operating lease cost 1,678,000   920,000  
Stock-based compensation 9,836,000   8,869,000  
Deferred income taxes 2,931,000   (2,000)  
Non-cash restructuring charges 0   (99,000)  
Operating Lease, Impairment Loss     12,500,000  
Amortization of Debt Discount (Premium) 0   3,433,000  
Other 1,004,000   112,000  
Changes in operating assets and liabilities:        
Accounts receivable, net 43,501,000   37,998,000  
Inventory (32,987,000)   (13,919,000)  
Prepaid expenses and other assets 14,925,000   (3,537,000)  
Accounts payable and other liabilities (123,247,000)   (56,132,000)  
Deferred revenue 965,000   3,499,000  
Net Cash Provided by (Used in) Operating Activities (73,407,000)   (25,492,000)  
Investing activities:        
Purchases of property and equipment, net (520,000)   (1,068,000)  
Purchases of marketable securities (23,111,000)   0  
Maturities of marketable securities 15,900,000   0  
Net cash used in investing activities (7,731,000)   (1,068,000)  
Financing activities:        
Proceeds from issuance of common stock 2,599,000   2,998,000  
Payment, Tax Withholding, Share-based Payment Arrangement (7,175,000)   (6,246,000)  
Payments for Repurchase of Common Stock (10,000,000)   0  
Payments for Repurchase of Common Stock 10,000,000   0  
Net cash used in financing activities (14,576,000)   (3,248,000)  
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (54,000)   (1,092,000)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (95,768,000)   (30,900,000)  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 305,319,000 $ 401,087,000 $ 296,754,000 $ 327,654,000
Interest Paid, Including Capitalized Interest, Operating and Investing Activities   $ 200,000    
v3.22.1
Condensed Consolidated Statements Stockholders' Equity (Deficit) - USD ($)
shares in Thousands
Total
Common Stock Including Additional Paid in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2020 $ 216,018,000 $ 980,147,000 $ (113,613,000) $ (650,516,000)
Beginning Balance (shares) at Dec. 31, 2020   151,119    
Common stock issued under employee benefit plans, net of shares withheld for tax 2,998,000 $ 2,998,000    
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation (6,246,000) $ 6,246,000    
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)   2,214    
Allocated share-based compensation expense 8,869,000 $ 8,869,000    
Net income (loss) (10,168,000)     (10,168,000)
Ending Balance at Mar. 31, 2021 211,471,000 $ 985,768,000 (113,613,000) (660,684,000)
Ending Balance (shares) at Mar. 31, 2021   153,333    
Beginning Balance at Dec. 31, 2021 615,914,000 $ 1,008,872,000 (113,613,000) (279,345,000)
Beginning Balance (shares) at Dec. 31, 2021   156,474    
Common stock issued under employee benefit plans, net of shares withheld for tax 2,371,000      
Share-based Payment Arrangement, Decrease for Tax Withholding Obligation (7,175,000) $ 7,175,000    
Common stock issued under employee benefit plans, net of shares withheld for tax (shares)   1,891    
Allocated share-based compensation expense 9,836,000 $ 9,836,000    
Treasury Stock, Value, Acquired, Cost Method $ (10,000,000)      
Stock Repurchased During Period, Shares (1,120)      
Stock Repurchased During Period, Value $ (10,000,000)      
Net income (loss) 5,685,000     5,685,000
Ending Balance at Mar. 31, 2022 $ 592,786,000 $ 935,674,000 $ (123,613,000) $ (219,275,000)
Ending Balance (shares) at Mar. 31, 2022   157,245    
Change in Accounting Principle, Accounting Standards Update, Adopted [true false] true      
v3.22.1
Summary of business and significant accounting policies
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Summary of business and significant accounting policies Summary of business and significant accounting policies
GoPro, Inc. and its subsidiaries (GoPro or the Company) make it easy for the world to capture and share itself in immersive and exciting ways, helping people get the most out of their photos and videos. The Company is committed to developing solutions that create an easy, seamless experience for consumers to capture, create, manage and share engaging personal content. To date, the Company’s cameras, mountable and wearable accessories, and subscription and service have generated substantially all of its revenue. The Company sells its products globally on its website, and through retailers and wholesale distributors. The Company’s global corporate headquarters are located in San Mateo, California.
Basis of presentation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (GAAP) for financial information set forth in the Accounting Standards Codification “ASC”, as published by the Financial Accounting Standards Board “FASB”, and with the applicable rules and regulations of the Securities and Exchange Commission “SEC”. The Company’s fiscal year ends on December 31, and its fiscal quarters end on March 31, June 30 and September 30.
The Company’s operating results, financial position and cash flows for fiscal year 2021 were negatively impacted by the COVID-19 pandemic. As the global impact of the pandemic continued to evolve in 2021, the Company utilized its direct-to-consumer sales channel strategy to maximize its reach to customers. This action, along with a reduction in on-going operating expenses, helped accelerate its ability to achieve consistent profitability in 2021.
The condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, that management believes are necessary for the fair statement of the Company's financial statements, but are not necessarily indicative of the results expected in future periods. The Condensed Consolidated Balance Sheet at December 31, 2021, has been derived from the audited financial statements at that date, but does not include all the disclosures required by GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K (Annual Report) for the year ended December 31, 2021.
In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This accounting standard update, which was adopted effective January 1, 2022, has a significant impact on the ongoing accounting of the 2022 and 2025 Convertible Senior Notes. Due to the adoption of this accounting standard update under the modified retrospective method, prior periods were not restated. Refer to section “Recent Accounting Standards” below for additional details on the adoption of this accounting standard update. There have been no other material changes in the Company’s critical accounting policies and estimates from those disclosed in its Annual Report.
Principles of consolidation. These condensed consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include those related to revenue recognition and the allocation of the transaction price (including sales incentives, sales returns and implied post contract support), inventory valuation, product warranty liabilities, the valuation, impairment and useful lives of long-lived assets (property and equipment, operating lease right-of-use assets, intangible assets and goodwill), fair value of convertible senior notes, and income taxes. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, including but not limited to the potential impacts arising from the COVID-19 pandemic, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The extent and continued impact of COVID-19 has been taken into account by management in making the significant assumptions and estimates related to the above; however, if the duration and spread of the outbreak, the impact
on the Company’s customers, and the effect on the Company’s contract manufacturers, vendors and supply chains is different from the Company’s estimates and assumptions, then actual results could differ materially. Given the uncertainty with respect to COVID-19, the Company’s estimates and assumptions may evolve as conditions change. To the extent there are material differences between the estimates and the actual results, future results of operations could be affected.
Comprehensive income (loss). For all periods presented, comprehensive income (loss) approximated net income (loss). Therefore, the Condensed Consolidated Statements of Comprehensive Income (Loss) have been omitted.
v3.22.1
Fair value measurements
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Fair Value measurements Fair value measurements
The Company’s assets that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows:
March 31, 2022December 31, 2021
(in thousands)Level 1Level 2TotalLevel 1Level 2Total
Cash equivalents (1):
Money market funds$201,425 $— $201,425 $183,304 $— $183,304 
Total cash equivalents$201,425 $— $201,425 $183,304 $— $183,304 
Marketable securities:
Commercial paper$— $66,609 $66,609 $— $72,323 $72,323 
Corporate debt securities— 34,840 34,840 — 41,108 41,108 
Government securities— 43,167 43,167 — 24,399 24,399 
Total marketable securities$— $144,616 $144,616 $— $137,830 $137,830 
(1)    Included in cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets. Cash balances were $103.9 million as of March 31, 2022 and $217.8 million as of December 31, 2021.
Cash equivalents are classified as Level 1 because the Company uses quoted market prices to determine their fair value. Marketable securities are classified as Level 2 because the Company uses alternative pricing sources and models utilizing market observable inputs to determine their fair value. The contractual maturities of available-for-sale marketable securities as of March 31, 2022 were all less than one year in duration. At March 31, 2022 and December 31, 2021, the Company had no financial assets or liabilities measured at fair value on a recurring basis that were classified as Level 3, which are valued based on inputs supported by little or no market activity.
At March 31, 2022 and December 31, 2021, the amortized cost of the Company’s cash equivalents and marketable securities approximated their fair value and there were no material realized or unrealized gains or losses, either individually or in the aggregate.
In April 2017, the Company issued $175.0 million principal amount of Convertible Senior Notes due 2022 (2022 Notes). In November 2020, the Company issued $143.8 million principal amount of Convertible Senior Notes due 2025 (2025 Notes) (see Note 4 Financing arrangements). The estimated fair value of the 2022 Notes and 2025 Notes is based on quoted market prices of the Company’s instruments in markets that are not active and are classified as Level 2 within the fair value hierarchy. The Company estimated the fair value of the 2022 Notes and 2025 Notes by evaluating quoted market prices and calculating the upfront cash payment a market participant would require to assume these obligations. The calculated fair value of the 2022 Notes was $125.0 million and $132.4 million as of March 31, 2022 and December 31, 2021, respectively, while the calculated fair value of the 2025 Notes was $166.1 million and $189.0 million as of March 31, 2022 and December 31, 2021, respectively. The calculated fair value is highly correlated to the Company’s stock price and as a result, significant changes to the Company’s stock price will have a significant impact on the calculated fair value of the 2025 Notes only. The 2022 Notes are not highly impacted by the Company’s stock price given the close proximity between the end of Q1 2022 and the maturity date.
On April 15, 2022, the Company repaid $125.0 million of principal and $2.2 million of accrued interest in cash to the debt holders to fully settle the 2022 Notes on the maturity date.
For certain other financial assets and liabilities, including accounts receivable, accounts payable and other current assets and liabilities, the carrying amounts approximate their fair value primarily due to the relatively short maturity of these balances.
The Company also measures certain non-financial assets at fair value on a nonrecurring basis, primarily goodwill, intangible assets and operating lease right-of-use assets, in connection with periodic evaluations for potential impairment.
v3.22.1
Condensed consolidated financial statement details
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidated financial statement details Condensed consolidated financial statement details
The following section provides details of selected balance sheet items.
Inventory
(in thousands)
March 31, 2022December 31, 2021
Components
$30,823 $10,761 
Finished goods
88,573 75,648 
Total inventory
$119,396 $86,409 
Property and equipment, net
(in thousands)
March 31, 2022December 31, 2021
Leasehold improvements$33,764 $33,764 
Production, engineering and other equipment46,264 45,641 
Tooling11,743 13,537 
Computers and software21,078 20,771 
Furniture and office equipment5,613 5,614 
Tradeshow equipment and other1,970 1,970 
Construction in progress31 480 
Gross property and equipment
120,463 121,777 
Less: Accumulated depreciation and amortization(103,169)(102,774)
Property and equipment, net
$17,294 $19,003 

Other long-term assets
(in thousands)
March 31, 2022December 31, 2021
Point of purchase (POP) displays
$2,220 $2,509 
Long-term deferred tax assets
278,760 274,430 
Deposits and other
8,777 8,238 
Intangible assets, net1562
Other long-term assets$289,772 $285,239 
Intangible assets are comprised of purchased technology, which have a useful life between 20-72 months, and an indefinite life asset. Amortization expense was $0.1 million and $0.7 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, all of the Company’s purchased technology intangible assets were fully amortized.
Accrued expenses and other current liabilities
(in thousands)
March 31, 2022December 31, 2021
Accrued liabilities$29,028 $34,989 
Accrued sales incentives
27,485 34,117 
Employee related liabilities7,647 19,024 
Return liability
6,472 9,263 
Warranty liability
7,691 8,268 
Inventory received
4,633 7,169 
Customer deposits
2,330 2,760 
Purchase order commitments
2,238 1,369 
Other
9,067 11,613 
Accrued expenses and other current liabilities$96,591 $128,572 

Product warranty
Three months ended March 31,
(in thousands)
20222021
Beginning balance
$8,842 $8,523 
Charged to cost of revenue
2,885 2,655 
Settlement of warranty claims
(3,715)(3,726)
Warranty liability
$8,012 $7,452 
At March 31, 2022 and December 31, 2021, $7.7 million and $8.3 million, respectively, of the warranty liability was recorded as a component of accrued expenses and other current liabilities, and $0.3 million and $0.5 million, respectively, was recorded as a component of other long-term liabilities
v3.22.1
Financing Arrangements
 3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Financing Arrangements Financing arrangements
2021 Credit Facility
In January 2021, the Company entered into a Credit Agreement (2021 Credit Agreement) which provides for a revolving credit facility (2021 Credit Facility) under which the Company may borrow up to an aggregate amount of $50.0 million. The 2021 Credit Facility will terminate and any outstanding borrowings become due and payable on the earlier of (i) January 2024 and (ii) unless the Company has cash in a specified deposit account in an amount equal to or greater than the amount required to repay the Company’s convertible notes due April 2022, 91 days prior to the maturity date of such convertible notes. Concurrently with the execution of the 2021 Credit Agreement in January 2021, the Company terminated its previous 2016 Credit Agreement, which would otherwise have matured in March 2021.
The amount that may be borrowed under the 2021 Credit Agreement may be based on a customary borrowing base calculation if the Company’s Asset Coverage Ratio is at any time less than 1.50. The Asset Coverage Ratio is defined as the ratio of (i) the sum of (a) the Company’s cash and cash equivalents in the United States plus specified percentages of other qualified debt investments (Qualified Cash) plus (b) specified percentages of the net book values of the Company’s accounts receivable and certain inventory to (ii) $50.0 million.
At the Company’s option, borrowed funds accrue interest at either (i) a floating rate per annum equal to the base rate plus a margin of from 0.50% to 1.00% depending on the Company’s Asset Coverage Ratio or (ii) a per annum rate equal to the rate at which dollar deposits are offered in the London interbank market plus a margin of from 1.50% to 2.00% depending on the Company’s Asset Coverage Ratio. The Company is required to pay a commitment fee on the unused portion of the 2021 Credit Facility of 0.375% to 0.50% per annum, based on the level of utilization of the 2021 Credit Facility. Amounts owed under the 2021 Credit Agreement are guaranteed by certain of the Company’s United States subsidiaries and secured by a first priority security interest in substantially
all of the assets of the Company and certain of its subsidiaries (other than intellectual property, which is subject to a negative pledge restricting grants of security interests to third parties).
The 2021 Credit Agreement contains customary representations, warranties, and affirmative and negative covenants. The negative covenants include restrictions on the incurrence of liens and indebtedness, certain investments, dividends, stock repurchases and other matters, all subject to certain exceptions. In addition, the Company is required to maintain Liquidity (the sum of unused availability under the credit facility and the Company’s Qualified Cash) of at least $55.0 million (of which at least $40.0 million shall be attributable to Qualified Cash), or, if the borrowing base is then in effect, minimum unused availability under the credit facility of at least $10.0 million. The 2021 Credit Agreement also includes customary events of default that include, among other things, non-payment of principal, interest or fees, inaccuracy of representations and warranties, violation of certain covenants, cross default to certain other indebtedness, bankruptcy and insolvency events, material judgments and change of control. Upon an event of default, the lender may, subject to customary cure rights, require the immediate payment of all amounts outstanding.
At March 31, 2022, the Company was in compliance with all financial covenants contained in the 2021 Credit Agreement. The Company has made no borrowings from the 2021 Credit Facility to date, however, there is an outstanding letter of credit of $5.2 million for certain duty related requirements. This was not collateralized by any cash on hand.
2022 Convertible Notes
In April 2017, the Company issued $175.0 million aggregate principal amount of 3.50% Convertible Senior Notes due 2022 (2022 Notes). The 2022 Notes are senior, unsecured obligations of GoPro with a maturity date of April 15, 2022. The 2022 Notes can be converted into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election, at an initial conversion rate of 94.0071 shares of Class A common stock per $1,000 principal amount of the 2022 Notes, which is equivalent to an initial conversion price of approximately $10.64 per share of common stock, subject to adjustment. The Company has historically paid interest on the 2022 Notes semi-annually in arrears on April 15 and October 15 of each year.

The indenture did not allow for early redemption of the 2022 Notes by the Company ,and no sinking fund was provided for the 2022 Notes. The indenture included customary terms and covenants, including certain events of default after which the 2022 Notes may be due and payable immediately.
Holders had the option to convert the 2022 Notes in multiples of $1,000 principal amount at any time prior to January 15, 2022, but only in the following circumstances:
•during any calendar quarter beginning after the calendar quarter ending on September 30, 2017, if the last reported sale price of Class A common stock for at least 20 trading days (whether or not consecutive) during the last 30 consecutive trading days of the immediately preceding fiscal quarter was greater than or equal to 130% of the conversion price of the 2022 Notes on each applicable trading day;
•during the five-business day period following any five consecutive trading day period in which the trading price for the 2022 Notes was less than 98% of the product of the last reported sale price of Class A common stock and the conversion rate for the 2022 Notes on each such trading day; or
•upon the occurrence of specified corporate events.

During the three months ended March 31, 2022 and 2021, the preceding conditions allowing holders of the 2022 Notes to early convert were not met.
At any time on or after January 15, 2022 until the second scheduled trading day immediately preceding the maturity date of the 2022 Notes on April 15, 2022, a holder could convert its 2022 Notes, in multiples of $1,000 principal amount. Holders of the 2022 Notes who converted their 2022 Notes in connection with a make-whole fundamental change (as defined in the indenture) were, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change prior to the maturity date, holders would, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the 2022 Notes at a repurchase price equal to 100% of the principal amount of the 2022 Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date. During the three months
ended March 31, 2022, these conditions allowing holders of the 2022 Notes to convert were not met.
Concurrently with the November 2020 issuance of the 2025 Notes, the Company used $56.2 million of the net cash proceeds from the 2025 Notes to repurchase $50.0 million principal amount of the 2022 Notes through an individual, privately negotiated transaction. The $56.2 million net cash proceeds were allocated between long-term debt (liability component) of $50.6 million and additional paid-in capital (equity component) of $5.4 million on the Condensed Consolidated Balance Sheets, and the remaining $0.2 million was related to the payment of interest. The fair value of the liability component was measured using rates determined for similar debt instruments without a conversion feature. The Company’s effective interest rate of 2.4% was based on the trading details of the 2022 Notes immediately prior to the repurchase date to determine the volatility of the 2022 Notes, and their remaining term. The cash consideration allocated to the equity component was calculated by deducting the fair value of the liability component and interest payment from the total aggregate cash consideration. The difference between the fair value of the 2022 Notes repurchased and the carrying value of $45.2 million resulted in a $5.4 million loss on extinguishment of debt.
In connection with the 2022 Notes offering, the Company entered into a prepaid forward stock repurchase transaction (Prepaid Forward) with a financial institution (Forward Counterparty). Pursuant to the Prepaid Forward, the Company used approximately $78.0 million of the net proceeds from the offering of the 2022 Notes to fund the Prepaid Forward. The aggregate number of shares of the Company’s Class A common stock underlying the Prepaid Forward was approximately 9.2 million. The original expiration date for the Prepaid Forward was April 15, 2022, with the option for early settlement in whole or in part. Upon settlement of the Prepaid Forward, the Forward Counterparty would deliver to the Company the number of shares of Class A common stock underlying the Prepaid Forward or the portion thereof being settled early. The shares purchased under the Prepaid Forward were treated as treasury stock on the Condensed Consolidated Balance Sheets (and not outstanding for purposes of the calculation of basic and diluted income (loss) per share), but remained outstanding for corporate law purposes, including for purposes of any future stockholders’ votes, until the Forward Counterparty delivers the shares underlying the Prepaid Forward to the Company.
In the fourth quarter of 2020, 8.8 million shares out of the 9.2 million shares of Class A common stock underlying the Prepaid Forward were early settled and delivered to the Company. In April 2021, the remaining 0.4 million shares of Class A common stock underlying the Prepaid Forward were early settled and delivered to the Company. There was no financial statement impact due to the return of shares; however, shares outstanding for corporate law purposes were reduced by the early settlement.
On April 15, 2022, the Company repaid $125.0 million of principal and $2.2 million of accrued interest in cash to the debt holders to fully settle the 2022 Notes on the maturity date. Since the Company’s average stock price did not exceed the initial conversion price of $10.64 of the 2022 Notes, there was no further dilution.
2025 Convertible Notes
In November 2020, the Company issued $125.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2025 and granted an option to the initial purchasers to purchase up to an additional $18.8 million aggregate principal amount of the 2025 Notes to cover over-allotments, of which $18.8 million was subsequently exercised during November 2020, resulting in a total issuance of $143.8 million aggregate principal amount of the 2025 Notes. The 2025 Notes are senior, unsecured obligations of GoPro and mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances. The 2025 Notes are convertible into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election, at an initial conversion rate of 107.1984 shares of Class A common stock per $1,000 principal amount of the 2025 Notes, which is equivalent to an initial conversion price of approximately $9.3285 per share of common stock, subject to adjustment. Based on current and projected liquidity, the Company has the intent and ability to deliver cash up to the principal amount of the 2025 Notes then outstanding upon conversion. The Company pays interest on the 2025 Notes semi-annually in arrears on May 15 and November 15 of each year.
The Company may redeem all or any portion of the 2025 Notes on or after November 20, 2023 for cash if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which
the Company provides the redemption notice, at a redemption price equal to 100% of the principal amount of the 2025 Notes to be redeemed, plus accrued interest and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the 2025 Notes. The indenture includes customary terms and covenants, including certain events of default after which the 2025 Notes may be due and payable immediately.
Holders have the option to convert the 2025 Notes in multiples of $1,000 principal amount at any time prior to August 15, 2025, but only in the following circumstances:
•during any calendar quarter beginning after the calendar quarter ending on March 31, 2021, if the last reported sale price of Class A common stock for at least 20 trading days (whether or not consecutive) during the last 30 consecutive trading days of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price of the 2025 Notes on each applicable trading day;
•during the five-business day period following any five consecutive trading day period in which the trading price for the 2025 Notes is less than 98% of the product of the last reported sale price of Class A common stock and the conversion rate for the 2025 Notes on each such trading day;
•if the Company calls any or all of the 2025 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately before the redemption date; or
•upon the occurrence of specified corporate events.
At any time on or after August 15, 2025 until the second scheduled trading day immediately preceding the maturity date of the 2025 Notes on November 15, 2025, a holder may convert its 2025 Notes, in multiples of $1,000 principal amount. Holders of the 2025 Notes who convert their 2025 Notes in connection with a make-whole fundamental change (as defined in the indenture) are, under certain circumstances, entitled to an increase in the conversion rate. In addition, in the event of a fundamental change prior to the maturity date, holders will, subject to certain conditions, have the right, at their option, to require the Company to repurchase for cash all or part of the 2025 Notes at a repurchase price equal to 100% of the principal amount of the 2025 Notes to be repurchased, plus accrued and unpaid interest up to, but excluding, the repurchase date. During the three months ended March 31, 2022, the conditions allowing holders of the 2025 Notes to convert were not met.
In connection with the offering of the 2025 Notes, the Company paid $10.2 million to enter into privately negotiated capped call transactions with certain financial institutions (Capped Calls). The Capped Calls have an initial strike price of $9.3285 per share, which corresponds to the initial conversion price of the 2025 Notes. The Capped Calls cover, subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the 2025 Notes, the number of Class A common stock initially underlying the 2025 Notes. The Capped Calls are generally expected to reduce potential dilution to the Company’s Class A common stock upon any conversion of the 2025 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2025 Notes, as the case may be, with such reduction and/or offset subject to a cap, initially equal to $12.0925, and is subject to certain adjustments under the terms of the Capped Call transactions. The Capped Calls will expire in November 2025, if not exercised earlier.
The Capped Calls are subject to adjustment upon the occurrence of specified extraordinary events affecting the Company, including merger events, tender offers and announcement events. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including nationalization, insolvency or delisting, changes in law, failures to deliver, insolvency filings and hedging disruptions. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the 2025 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders’ equity as a reduction to additional paid-in capital and will not be remeasured as long as they continue to meet certain accounting criteria.
Accounting for the 2022 and 2025 Convertible Notes
Pre adoption of ASU 2020-06
The 2022 and 2025 Convertible Notes were separated into liability and equity components for accounting purposes. The carrying amounts of the liability component were initially calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amounts of the equity component
representing the conversion option were determined by deducting the fair value of the liability component from the par value of the respective Convertible Senior Notes. This difference represents the debt discount that was amortized to interest expense over the respective terms of the 2022 Notes and 2025 Notes using the effective interest rate method. Upon issuance, the carrying amounts of the liability component from the issuance of the 2022 Notes and the 2025 Notes of $128.3 million and $106.9 million, respectively were recorded in long-term debt on the Condensed Consolidated Balance Sheets. The carrying amounts of the equity component representing the conversion option was determined to be $46.7 million and $36.9 million for the 2022 Notes and 2025 Notes, respectively, upon issuance. The equity component was recorded in additional paid-in-capital and is not remeasured so long as it continued to meet the conditions for equity classification.
The liability component was accreted up to the face value of the 2022 Notes of $175.0 million and 2025 Notes of $143.8 million, which resulted in additional non-cash interest expense being recognized in the Condensed Consolidated Statements of Operations. The accretion of the 2022 Notes and 2025 Notes to par to long-term debt was amortized into interest expense over the term of the 2022 Note and 2025 Notes using an effective interest rate of approximately 10.5% and 7.5%, respectively.
In accounting for the debt issuance costs of $5.7 million and $4.7 million related to the 2022 Notes and 2025 Notes, respectively, the Company allocated each of the total amounts incurred to the liability and equity components of the 2022 Notes and 2025 Notes based on their relative values. Issuance costs attributable to the liability component of the 2022 Notes were $4.2 million upon issuance and were amortized, along with the debt discount, to interest expense over the contractual term of the 2022 Notes at an effective interest rate of 10.5%. Issuance costs attributable to the liability component of the 2025 Notes were $3.5 million upon issuance and were amortized, along with the debt discount, to interest expense over the contractual term of the 2025 Notes at an effective interest rate of 7.5%. Issuance costs attributable to the equity component were $1.5 million and $1.2 million for the 2022 Notes and 2025 Notes, respectively, and were netted against the equity component representing the conversion option in additional paid-in-capital.
Post adoption of ASU 2020-06
On January 1, 2022, the Company adopted ASU 2020-06 based on the modified retrospective transition method. Under such transition, prior-period information has not been retrospectively adjusted. Upon adoption of ASU 2020-06, the Company is no longer recording the conversion feature of its 2022 Notes and 2025 Notes in equity. Instead, the Company combined the previously separated equity component with the liability component, which together are now classified as debt, thereby eliminating the subsequent amortization of the debt discount as interest expense. Similarly, the portion of debt issuance costs previously allocated to equity was reclassified to debt and amortized as interest expense. Accordingly, the Company recorded a decrease to additional paid-in-capital of $78.2 million, a decrease to accumulated deficit of $47.1 million, and an increase to the 2022 Notes and 2025 Notes of $2.3 million and $28.8 million, respectively. In addition, the Company recorded the reversal of U.S. deferred tax liabilities (net) of $7.3 million associated with the 2022 Notes and 2025 Notes upon the adoption of ASU 2020-06, with a corresponding decrease to accumulated deficit for the same amount.
As of March 31, 2022 and December 31, 2021, the outstanding principal on the 2022 Notes was $125.0 million, the unamortized debt discount was zero and $2.4 million, respectively, the unamortized debt issuance cost was $0.1 million and $0.2 million, respectively, and the net carrying amount of the liability was $124.9 million and $122.4 million, respectively, which was recorded as short-term debt within the Condensed Consolidated Balance Sheets. For the three months ended March 31, 2022, and 2021, the Company recorded interest expense of $1.1 million and $1.1 million, respectively, for contractual coupon interest, and zero and $1.9 million, respectively, for amortization of the debt discount. For the three months ended March 31, 2022 and 2021, the Company recorded $0.2 million and $0.1 million for amortization of debt issuance costs, respectively.
As of March 31, 2022 and December 31, 2021, the outstanding principal on the 2025 Notes was $143.8 million, the unamortized debt discount was zero and $29.7 million, respectively, the unamortized debt issuance cost was $3.4 million and $2.7 million, respectively, and the net carrying amount of the liability was $140.3 million and $111.3 million, respectively, which was recorded as long-term debt within the Condensed Consolidated Balance Sheets. For the three months ended March 31, 2022 and 2021, the Company recorded interest expense of $0.4 million and $0.4 million for contractual coupon interest, $0.2 million and $0.2 million for amortization of debt issuance costs, and zero and $1.6 million for amortization of the debt discount.
v3.22.1
Stockholders' equity
 3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Stock Repurchase Program. On January 27, 2022, the Company’s board of directors authorized the repurchase of up to $100 million of its Class A capital stock. Stock repurchases under the program may be made periodically using a variety of methods, including without limitation, open market purchases, block trades or otherwise in compliance with all federal and state securities laws and state corporate law and in accordance with the single broker, timing, price, and volume guidelines set forth in Rule 10b-18 under the Securities Exchange Act of 1934, as amended, as such guidelines may be modified by the SEC from time to time. This stock repurchase program has no time limit and may be modified, suspended, or discontinued at any time. The Company currently intends to hold its repurchased shares as treasury stock.
As of March 31, 2022, the remaining amount of share repurchases under the program was $90 million. The following table summarizes share repurchases during the three months ended March 31, 2022. There were no share repurchases during the three months ended March 31, 2021.

Three months ended March 31, 2022
(in thousands, except per share data)
Shares repurchased1,120 
Average price per share$8.93 
Value of shares repurchased$10,000 
v3.22.1
Employee benefit plans
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Employee benefit plans Equity incentive plans. The Company has outstanding equity grants from its three stock-based employee compensation plans: the 2014 Equity Incentive Plan (2014 Plan), the 2010 Equity Incentive Plan (2010 Plan) and the 2014 Employee Stock Purchase Plan (ESPP). No new options or awards have been granted under the 2010 Plan since June 2014. Outstanding options and awards under the 2010 Plan continue to be subject to the terms and conditions of the 2010 Plan. Options granted under the 2014 Plan generally expire within ten years from the date of grant and generally vest over one to four years. Restricted stock units (RSUs) granted under the 2014 Plan generally vest over two to four years based upon continued service and are settled at vesting in shares of the Company’s Class A common stock. Performance stock units (PSUs) granted under the 2014 Plan generally vest over three years based upon continued service and the Company achieving certain financial and operating targets, and are settled at vesting in shares of the Company’s Class A common stock. The Company accounts for forfeitures of stock-based payment awards in the period they occur. The ESPP allows eligible employees to purchase shares of the Company’s Class A common stock through payroll deductions at a price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six-month offering period. For additional information regarding the Company’s equity incentive plans, refer to the 2021 Annual Report.
Stock options
A summary of the Company’s stock option activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average exercise price
Weighted-average remaining contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding at December 31, 20213,080 $9.18 5.92$8,735 
Granted321 8.70 
Exercised(20)5.93 
Forfeited/Cancelled(22)13.95 
Outstanding at March 31, 20223,359 $9.12 6.10$4,914 
Vested and expected to vest at March 31, 20223,359 $9.12 6.10$4,914 
Exercisable at March 31, 20222,273 $10.38 4.87$2,636 
The aggregate intrinsic value of the stock options outstanding as of March 31, 2022 represents the value of the Company’s closing stock price on March 31, 2022 in excess of the exercise price multiplied by the number of options outstanding.
Restricted stock units
A summary of the Company’s RSU activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20218,714 $6.52 
Granted2,988 9.01 
Vested(1,990)5.92 
Forfeited(238)7.17 
Non-vested shares at March 31, 20229,474 $7.42 
Performance stock units
A summary of the Company’s PSU activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20211,134 

$6.68 
Granted604 8.70 
Vested(352)7.09 
Forfeited— — 
Non-vested shares at March 31, 20221,386 $7.46 
Employee stock purchase plan. For the three months ended March 31, 2022 and 2021, the Company issued 0.3 million and 0.5 million shares under its ESPP, respectively, at weighted-average prices of $7.70 and $4.15, respectively.
v3.22.1
Net loss per share
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Net loss per share
Prior to the adoption of ASU 2020-06, the Company calculated the potential dilutive effect of its 2022 Notes and 2025 Notes under the treasury stock method. As a result, only the amount by which the conversion value exceeded the aggregate principal amount of the 2022 Notes and 2025 Notes (the “conversion spread”) was considered in the diluted net income (loss) per share computation. The conversion spread was dilutive in periods of net income when the average market price of the Company’s Class A common stock for a given reporting period exceeded the initial conversion prices of $10.64 and $9.3285 per share for the 2022 Notes and 2025 Notes, respectively. The shares included in total anti-dilutive shares relate to the 2025 Notes and were calculated based on the average market price of the Company’s Class A Common Stock for the three months ended March 31, 2021. The initial conversion price of the 2022 Notes was greater than the average market price of the Company’s Class A Common Stock for the three months ended March 31, 2021 and as such, had no impact on anti-dilutive or dilutive share calculations. Upon conversion of the 2025 Notes, there will be no economic dilution until the average market price of the Company’s Class A common stock exceeds the cap price of $12.0925 per share, as exercise of the Capped Calls offset any dilution from the 2025 Notes from the initial conversion price up to the cap price. The Capped Calls are excluded from diluted net income per share as they would be anti-dilutive.
The Company’s 2022 Notes mature on April 15, 2022 and the 2025 Notes mature on November 15, 2025, unless earlier repurchased or converted into shares of Class A common stock under certain circumstances as described further in Note 4 Financing arrangements. The 2022 Notes and 2025 Notes are convertible into cash, shares of the Company’s Class A common stock, or a combination thereof, at the Company’s election. While the Company has the intent and ability to deliver cash up to the principal amount, the maximum number of shares issuable upon conversion of the 2022 Notes is 20.6 million shares of Class A common stock and 20.8 million shares of Class A common stock upon conversion of the 2025 Notes. On April 15, 2022, the Company repaid $125.0 million of principal and $2.2 million of accrued interest in cash to the debt holders to fully settle the 2022 Notes on the maturity date. The repayment of the 2022 Notes did not have an impact on earnings per share for the periods ended March 31, 2022 and March 31, 2021.
Additionally, the calculation of weighted-average shares outstanding for the three months ended March 31, 2021 excludes approximately 9.2 million shares effectively repurchased and held in treasury stock on the Condensed Consolidated Balance Sheets as a result of the Prepaid Forward transaction entered into in connection with the 2022 Note offering.
Upon the adoption of ASU 2020-06 on January 1, 2022, the Company calculated the potential dilutive effect of its 2022 Notes and 2025 Notes under the if-converted method. Under the if-converted method, diluted net income (loss) per share was determined by assuming that all of the 2022 Notes and the 2025 Notes were converted into shares of the Company’s common stock at the beginning of the reporting period. In addition, interest charges on the 2022 Notes and 2025 Notes, which includes both coupon interest and the amortization of debt issuance costs, were added back to the numerator on an after-tax effected basis.
The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to ten votes per share. Each share of Class B common stock is convertible at any time at the option of the stockholder into one share of Class A common stock and has no expiration date. Each share of Class B common stock will convert automatically into one share of Class A common stock upon the date when the outstanding shares of Class B common stock represent less than 10% of the aggregate number of shares of common stock then outstanding. Class A common stock is not convertible into Class B common stock.
The computation of the diluted net income (loss) per share of Class A common stock assumes the conversion of Class B common stock.
v3.22.1
Income taxes
 3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
Income taxes
8. Income taxes
The Company’s income tax expense (benefit) and the resulting effective tax rate are based upon the estimated annual effective tax rates applicable for the respective period, including losses generated in countries where the Company is projecting annual losses for which deferred tax assets are not anticipated to be recognized.
The Company’s tax provision and the resulting effective tax rate for interim periods is determined based upon its estimated annual effective tax rate, adjusted for the effect of discrete items arising in that quarter. The Company also excludes jurisdictions with a projected loss for the year (or year-to-date loss) where the Company cannot or does not expect to recognize a tax benefit from its estimated annual effective tax rate. The impact of such inclusions could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.
Three months ended March 31,
(dollars in thousands)20222021
Income tax expense (benefit)$(51)$1,219 
The Company recorded an income tax benefit of $0.1 million for the three months ended March 31, 2022, on pre-tax net income of $5.6 million. The Company’s income tax benefit for the three months ended March 31, 2022, was composed of $1.4 million of tax expense incurred on pre-tax income, and discrete items that primarily included $1.4 million of net excess tax benefit for employee stock-based compensation.
For the three months ended March 31, 2021, the Company recorded an income tax expense of $1.2 million on a pre-tax net loss of $8.9 million. The Company’s income tax expense for the three months ended March 31, 2021 was composed of $1.3 million of tax expense incurred on pre-tax net income, and discrete items that primarily included $1.8 million of net excess tax benefit for employee stock-based compensation and $0.2 million tax benefit related to foreign provision to return adjustments, partially offset by a net increase in the valuation allowance of $2.0 million.
At March 31, 2022 and December 31, 2021, the Company’s gross unrecognized tax benefits were $21.8 million and $21.3 million, respectively. If recognized, $7.9 million of these unrecognized tax benefits (net of United States federal benefit) at March 31, 2022 would reduce income tax expense. The unrecognized tax benefits relate primarily to unresolved matters with taxing authorities regarding the Company’s transfer pricing positions. While it is often difficult to predict the final outcome or the timing of resolution of any particular uncertain tax position, the Company believes that its reserves reflect the more likely outcome. The Company believes, due to statute of limitations expiration, that within the next 12 months, it is possible that up to $0.5 million of uncertain tax position could be released. It is also reasonably possible that additional uncertain tax positions will be added. It is not reasonably possible at this time to quantify the net effect.
v3.22.1
Commitments, contingencies and guarantees
 3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments, contingencies and guarantees Facility Leases. The Company leases its facilities under long-term operating leases, which expire at various dates through 2027.
The components of net lease cost, which were recorded in operating expenses, were as follows:
Three months ended March 31,
(in thousands)20222021
Operating lease cost (1)
$2,850 $3,096 
Sublease income(731)(133)
Net lease cost$2,119 $2,963 
(1)    Operating lease cost includes variable lease costs, which are immaterial.
Supplemental cash flow information related to leases was as follows:
Three months ended March 31,
(in thousands)20222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$3,777 $3,690 
Right-of-use assets obtained in exchange for operating lease liabilities— 821 

Supplemental balance sheet information related to leases was as follows:
March 31, 2022December 31, 2021
Weighted-average remaining lease term (in years) - operating leases4.434.64
Weighted-average discount rate - operating leases6.1%6.0%

As of March 31, 2022, maturities of operating lease liabilities were as follows:
(in thousands)
March 31, 2022
2022 (remaining 9 months)9,205 
202312,758 
202411,748 
202511,477 
202611,710 
Thereafter974 
Total lease payments57,872 
Less: Imputed interest(7,803)
Present value of lease liabilities$50,069 
Other Commitments. In the ordinary course of business, the Company enters into multi-year agreements to purchase sponsorships with event organizers, resorts and athletes as part of its marketing efforts; software licenses related to its financial and IT systems; debt agreements; and various other contractual commitments. As of March 31, 2022, the Company’s total undiscounted future expected obligations under multi-year agreements described above with terms longer than one year was $348.5 million.
Legal proceedings and investigations. On January 5, 2015, Contour LLC filed a complaint against the Company in federal court in Utah alleging, among other things, patent infringement in relation to certain GoPro cameras. GoPro filed an inter partes review (IPR) at the United States Patent and Trademark Office. On November 30, 2015, Contour dismissed the Utah action, and Contour IP Holdings LLC (CIPH), a non-practicing entity, re-filed a similar complaint in Delaware. The case was transferred to the Northern District of California in July 2017 (case 3:17-cv-04738) and was stayed pending the IPR proceedings. Upon conclusion of the IPRs, the District Court lifted the stay on October 1, 2019. Due to COVID-19 delays, the trial was delayed several times. Separately, on March 26, 2021, CIPH filed a new lawsuit against Company in the same court (case 3:21-cv-02143), asserting the same patents against certain GoPro products. The Court granted Company’s motion for summary judgment that the asserted patents are invalid under 35 U.S.C. 101 for claiming unpatentable subject matter on March 4, 2022, and entered judgment in favor of Company and against CIPH on March 15, 2022. CIPH filed a notice of appeal on April 13, 2022. The Company believes that the matters lack merit, and intends to vigorously defend against CIPH.
The Company regularly evaluates the associated developments of the legal proceedings described above, as well as other legal proceedings that arise in the ordinary course of business. While litigation is inherently uncertain, based on the currently available information, the Company is unable to determine a loss or a range of loss, and does not believe the ultimate cost to resolve these matters will have a material adverse effect on its business, financial condition, cash flows or results of operations.
Indemnifications. The Company has entered into indemnification agreements with its directors and executive officers which requires the Company to indemnify its directors and executive officers against liabilities that may arise by reason of their status or service. In addition, in the normal course of business, the Company enters into agreements that contain a variety of representations and warranties, and provide for general indemnification. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but have not yet been made. It is not possible to determine the maximum potential amount under these indemnification agreements due to the Company’s limited history with indemnification claims and the unique facts and circumstances involved in each particular agreement. As of March 31, 2022, the Company has not paid any claims nor has it been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.
v3.22.1
Concentrations of risk and geographic information
 3 Months Ended
Mar. 31, 2022
Risks and Uncertainties [Abstract]  
Concentrations of risk and segment information Concentrations of risk and geographic information Concentration of risk. Financial instruments which potentially subject the Company to concentration of credit risk includes cash and cash equivalents, marketable securities, accounts receivable, and derivative instruments, including the Capped Calls associated with the 2025 Notes. The Company places cash and cash equivalents with high-credit-quality financial institutions; however, the Company maintains cash balances in excess of the FDIC insurance limits. The Company believes that credit risk for accounts receivable is mitigated by the Company’s credit evaluation process, relatively short collection terms and dispersion of its customer base. The Company generally does not require collateral and losses on trade receivables have historically been within management’s expectations. The Company believes its counterparty credit risk related to its derivative instruments is mitigated by transacting with major financial institutions with high credit ratings.
Customers who represented 10% or more of the Company’s net accounts receivable balance were as follows:
March 31, 2022December 31, 2021
Customer A17%18%
Customer B19%30%
Customer C13%*
* Less than 10% of net accounts receivable for the period indicated.
The following table summarizes the Company’s accounts receivables sold, without recourse, and factoring fees paid:
Three months ended March 31,
(in thousands)
20222021
Accounts receivable sold$23,949 $30,734 
Factoring fees53 207 
Third-party customers who represented 10% or more of the Company’s total revenue were as follows:
Three months ended March 31,
20222021
Customer A*11%
* Less than 10% of total revenue for the period indicated.
Supplier concentration. The Company relies on third parties for the supply and manufacture of its products, some of which are sole-source suppliers. The Company believes that outsourcing manufacturing enables greater scale and flexibility. As demand and product lines change, the Company periodically evaluates the need and advisability of adding manufacturers to support its operations. In instances where a supply and manufacture agreement does not exist or suppliers fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers on time, if at all. The Company also relies on third parties with whom it outsources supply chain activities related to inventory warehousing, order fulfillment, distribution and other direct sales logistics. In instances where an outsourcing agreement does not exist or these third parties fail to perform their obligations, the Company may be unable to find alternative partners or satisfactorily deliver its products to its customers on time.
Geographic information
Revenue by geographic region was as follows:
Three months ended March 31,
(in thousands)
20222021
Americas
$102,583 $106,638 
Europe, Middle East and Africa (EMEA)
61,531 49,803 
Asia and Pacific (APAC)
52,591 47,239 
Total revenue
$216,705 $203,680 
Revenue from the United States, which is included in the Americas geographic region, was $85.2 million and $93.3 million for the three months ended March 31, 2022 and 2021, respectively. No other individual country exceeded 10% of total revenue for any period presented. The Company does not disclose revenue by product category as it does not track sales incentives and other revenue adjustments by product category to report such data.
As of March 31, 2022 and December 31, 2021, long-lived assets, which represent net property and equipment, located outside the United States, primarily in Hong Kong and mainland China, were $5.3 million and $5.7 million, respectively.
v3.22.1
Subsequent Events
 1 Months Ended 3 Months Ended
Nov. 04, 2021
Mar. 31, 2022
Subsequent Event [Line Items]    
Subsequent Events [Text Block]
12. Subsequent events
On January 27, 2022, the Company’s board of directors authorized the repurchase of up to $100 million of its Class A common stock. Stock repurchases under the program may be made periodically through open market purchases, block trades or otherwise in compliance with all federal and state securities laws and state corporate law and in accordance with the single broker, timing, price, and volume guidelines set forth in Rule 10b-18 under the Securities Exchange Act of 1934, as amended, as such guidelines may be modified by the SEC from time to time. This stock repurchase program has no time limit and may be modified, suspended, or discontinued at any time.
 On January 27, 2022, the Company’s board of directors authorized the repurchase of up to $100 million of its Class A common stock. Stock repurchases under the program may be made periodically through open market purchases, block trades or otherwise in compliance with all federal and state securities laws and state corporate law and in accordance with the single broker, timing, price, and volume guidelines set forth in Rule 10b-18 under the Securities Exchange Act of 1934, as amended, as such guidelines may be modified by the SEC from time to time. This stock repurchase program has no time limit and may be modified, suspended, or discontinued at any time.
v3.22.1
Summary of business and significant accounting policies (Policies)
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (GAAP) for financial information set forth in the Accounting Standards Codification “ASC”, as published by the Financial Accounting Standards Board “FASB”, and with the applicable rules and regulations of the Securities and Exchange Commission “SEC”. The Company’s fiscal year ends on December 31, and its fiscal quarters end on March 31, June 30 and September 30.
The Company’s operating results, financial position and cash flows for fiscal year 2021 were negatively impacted by the COVID-19 pandemic. As the global impact of the pandemic continued to evolve in 2021, the Company utilized its direct-to-consumer sales channel strategy to maximize its reach to customers. This action, along with a reduction in on-going operating expenses, helped accelerate its ability to achieve consistent profitability in 2021.
The condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, that management believes are necessary for the fair statement of the Company's financial statements, but are not necessarily indicative of the results expected in future periods. The Condensed Consolidated Balance Sheet at December 31, 2021, has been derived from the audited financial statements at that date, but does not include all the disclosures required by GAAP. This Quarterly Report on Form 10-Q should be read in conjunction with the Company's Annual Report on Form 10-K (Annual Report) for the year ended December 31, 2021.
In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This accounting standard update, which was adopted effective January 1, 2022, has a significant impact on the ongoing accounting of the 2022 and 2025 Convertible Senior Notes. Due to the adoption of this accounting standard update under the modified retrospective method, prior periods were not restated. Refer to section “Recent Accounting Standards” below for additional details on the adoption of this accounting standard update. There have been no other material changes in the Company’s critical accounting policies and estimates from those disclosed in its Annual Report.
Principles of consolidation Principles of consolidation. These condensed consolidated financial statements include all the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of estimates Use of estimates. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the Company’s condensed consolidated financial statements and accompanying notes. Significant estimates and assumptions made by management include those related to revenue recognition and the allocation of the transaction price (including sales incentives, sales returns and implied post contract support), inventory valuation, product warranty liabilities, the valuation, impairment and useful lives of long-lived assets (property and equipment, operating lease right-of-use assets, intangible assets and goodwill), fair value of convertible senior notes, and income taxes. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, including but not limited to the potential impacts arising from the COVID-19 pandemic, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The extent and continued impact of COVID-19 has been taken into account by management in making the significant assumptions and estimates related to the above; however, if the duration and spread of the outbreak, the impact on the Company’s customers, and the effect on the Company’s contract manufacturers, vendors and supply chains is different from the Company’s estimates and assumptions, then actual results could differ materially. Given the uncertainty with respect to COVID-19, the Company’s estimates and assumptions may evolve as conditions change. To the extent there are material differences between the estimates and the actual results, future results of operations could be affected.
Comprehensive income (loss) Comprehensive income (loss). For all periods presented, comprehensive income (loss) approximated net income (loss). Therefore, the Condensed Consolidated Statements of Comprehensive Income (Loss) have been omitted
Cash, Cash Equivalents, and Marketable Securities Cash equivalents and marketable securities. Cash equivalents consist of investments in money market funds with maturities of three months or less from the date of purchase. Marketable securities consist of commercial paper, government securities and corporate debt securities, and are classified as available-for-sale securities. The Company views these securities as available to support current operations and has classified all available-for-sale securities as current assets. Available-for-sale securities are carried at fair value with unrealized gains and losses, if any, included in stockholders’ equity. Unrealized gains and losses are charged against other income (expense), net, for declines in fair value below the cost of an individual investment that is deemed to be other than temporary. The Company has not identified any marketable securities as other-than-temporarily impaired for the periods presented. The cost of securities sold is based upon a specific identification method.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy Restricted cash. As of December 31, 2022 and 2021, the Company had an outstanding letter of credit collateralized by a money market account of zero and $— million, respectively, for certain duty related requirements.
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy Accounts receivable. Accounts receivable are stated at invoice value less estimated allowances for doubtful accounts. Allowances are recorded based on the Company’s assessment of various factors, such as: historical experience, credit quality of its customers, age of the accounts receivable balances, geographic related risks, economic conditions and other factors that may affect a customer’s ability to pay. The allowance for doubtful accounts as of March 31, 2022 and 2021 was $0.7 million and $0.7 million, respectively.
Inventory, Policy Inventory. Inventory consists of finished goods and component parts, which are purchased directly from contract manufacturers or from suppliers. Inventory is stated at the lower of cost or net realizable value on a first-in, first-out basis. The Company writes down its inventory for estimated obsolescence or excess inventory equal to the difference between the cost of inventory and estimated market value plus the estimated cost to sell. The Company’s assessment of market value is based upon assumptions around market conditions and estimated future demand for its products within a specified time horizon, generally 12 months, product life cycle status, product development plans and current sales levels. Adjustments to reduce inventory to net realizable value are recognized in cost of revenue.
Advertising Costs, Policy, Capitalized Direct Response Advertising Point of purchase (POP) displays. The Company provides retailers with POP displays, generally free of charge, in order to facilitate the marketing of the Company’s products within retail stores. The POP displays contain a display that broadcasts video images taken by GoPro cameras along with product placement available for cameras and accessories. POP display costs are capitalized as long-term assets and charged to sales and marketing expense over the expected period of benefit, which generally ranges from 24 to 36 months. Cash outflows and amortization related to POP displays are classified as operating activities in the consolidated statement of cash flows.Amortization expense for POP displays was $2.8 million, $2.8 million and $4.2 million in 2022, 2021 and 2020, respectively.
Property, Plant and Equipment, Policy
Property and equipment, net. Property and equipment are stated at cost and are depreciated using the straight-line method over the estimated useful life of the assets, ranging from one to nine years. Leasehold improvements are amortized over the shorter of the lease term or their expected useful life. Property and equipment pending installation, configuration or qualification are classified as construction in progress. Costs of maintenance and repairs that do not improve or extend the lives of the respective assets are expensed as incurred.
Depreciation expense was $9.8 million, $9.8 million and $14.5 million in 2022, 2021 and 2020, respectively. In 2020, the Company recorded accelerated depreciation charges in connection with its plans to vacate certain leased office facilities as disclosed in Note 11 Restructuring charges.
Fair Value Measurement, Policy
Fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the reporting date. The Company estimates and categorizes the fair value of its financial assets by applying the following hierarchy:
Level 1
Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to directly access.
Level 2
Valuations based on quoted prices for similar assets or liabilities; valuations for interest-bearing securities based on non-daily quoted prices in active markets; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
Level 3
Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
Leases
Leases. The Company leases its office space and facilities under cancelable and non-cancelable operating leases. Operating leases are presented as operating lease right-of-use (ROU) assets, short-term operating lease liabilities and long-term operating lease liabilities on the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to control the use of an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease.
Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of future lease payments. The Company determines its incremental borrowing rate based on the approximate rate at which the Company would borrow, on a secured basis, to calculate the present value of future lease payments. Lease expenses are recognized on a straight-line basis over the lease term. Certain leases include an option to renew with terms that can extend the lease term from one to five years. The exercise of a lease renewal option is at the Company’s sole discretion and is included in the lease term when the Company is reasonably certain it will exercise the option.
Prior to January 1, 2019, the Company recognized leases under Accounting Standards Codification (ASC) 840, Leases, which had the following differences from the current lease standard, ASC 842, Leases:
•Operating leases were previously not recorded on the Company’s Consolidated Balance Sheets.
•The Company calculated a liability for future costs to be incurred under a lease for its remaining term without economic benefit to the Company upon determination of a cease-use date. The fair value of the liability was determined based on remaining lease payments, estimated sublease income and the effects of any prepaid or deferred items recognized under the lease.
Goodwill and Intangible Assets, Policy Goodwill and acquired intangible assets. Goodwill represents the excess of the purchase price over the fair value of the net assets acquired in a business combination. Acquired intangible assets other than goodwill are amortized over their useful lives unless the lives are determined to be indefinite. For intangible assets acquired in a business combination, the determination of the estimated fair values of the assets received involves significant judgments and estimates. These judgments can include, but are not limited to, the cash flows that an asset is expected to generate in the future, technology obsolescence, and the appropriated weighted-average cost of capital. Valuation approaches consistent with the market approach, income approach and/or cost approach are used to measure fair value.
Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy
Impairment of goodwill and long-lived assets. The Company performs an annual assessment of its goodwill during the fourth quarter of each calendar year or more frequently if indicators of potential impairment exist, such as an adverse change in business climate or a decline in the overall industry demand, that would indicate it is more likely than not that the fair value of its single reporting unit is less than its carrying value. There was no impairment of goodwill recorded for any periods presented. For the Company’s annual impairment testing in 2022, the Company did not identify any indicators of potential impairment of its single reporting unit. Other indefinite-lived intangible assets are assessed for impairment at least annually. If their carrying value exceeds the estimated fair value, the difference is recorded as an impairment.
Long-lived assets, such as property and equipment, intangible assets subject to amortization and right-of-use assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount to the estimated future undiscounted cash flows expected to be generated by the asset group. If it is determined that an asset group is not recoverable, an impairment charge is recognized for the amount by which the carrying amount of the asset group exceeds its fair value. The Company recorded a $12.5 million right-of-use asset impairment in 2021 primarily related to its headquarter campus as described further in Note 11 Restructuring charges. The Company used the following significant assumptions to determine the impairment charge: future sublease rental rates, future sublease market conditions and a discount rate based on the weighted-average cost of capital. The Company did not record any impairment charges in 2021 or 2019.
Standard Product Warranty, Policy Warranty. The Company records a liability for estimated product warranty costs at the time product revenue is recognized. The Company’s standard warranty obligation to its end-users generally provides a 12-month warranty coverage on all of its products except in the European Union where the Company provides a 24-month warranty. The Company also offers extended warranty programs for a fee. The Company’s estimate of costs to service its warranty obligations is based on its historical experience of repair and replacement of the associated products and expectations of future conditions. The warranty obligation is affected by product failure rates and the related use of materials, labor costs and freight incurred in correcting any product failure.
Debt, Policy
Convertible Senior Notes. In April 2017, the Company issued $175.0 million aggregate principal amount of 3.50% Convertible Senior Notes due April 15, 2022 (2022 Notes). In November 2020, the Company issued $143.8 million aggregate principal amount of 1.25% Convertible Senior Notes due November 15, 2025 (2025 Notes). Concurrently with the issuance of the 2025 Notes, the Company used a portion of the net proceeds to repurchase part of the 2022 Notes. See Note 4 Financing Arrangements for additional details.
The Company accounts for its 2022 Notes and 2025 Notes in accordance with ASC 470-20, Debt with Conversion and Other Options. As the Company’s 2022 Notes and 2025 Notes have a net settlement feature and may be settled wholly or partially in cash upon conversion, the Company is required to separately account for the liability (debt) and equity (conversion option) components of the instrument. The carrying amount of the liability component of the instrument is determined by estimating the fair value of a similar liability without the conversion option using income and market based approaches. The amount of the equity component is then calculated by deducting the fair value of the liability component from the principal amount of the instrument. The difference between the principal amount and the liability component represents a debt discount that is amortized to interest expense over the remaining term of the convertible senior notes using an effective interest rate method. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. In accounting for the issuance costs related to the 2022 Notes and 2025 Notes, the allocation of issuance costs incurred between the liability and equity components were based on their relative values.
The total consideration for the 2022 Notes partial repurchase was separated into liability and equity components by estimating the fair value of a similar liability without a conversion option and assigning the residual value to the equity component. The effective interest rate used to estimate the fair value of the liability component of the 2022 Notes partial repurchase is based on the income approach used to determine the effective interest rate of the 2025 Notes, adjusted for the remaining term of the 2022 Notes. The gain or loss on extinguishment of the debt was subsequently determined by comparing repurchase consideration allocated to the liability component to the sum of the carrying value of the liability component, net of the proportionate amounts of unamortized debt discount and remaining unamortized debt issuance costs.
In August 2020, the FASB issued ASU 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. This accounting standard update, which we adopted effective January 1, 2022, will have a significant impact on the ongoing accounting of the 2022 and 2025 Notes. Refer to section “Recent Accounting Pronouncements” for additional details on the adoption of this accounting standard update.
Revenue recognition
Revenue recognition. The Company derives substantially all of its revenue from the sale of cameras, mounts, accessories, subscription and service, and implied post contract support to customers. The transaction price recognized as revenue represents the consideration the Company expects to be entitled to and is primarily comprised of product revenue, net of returns and variable consideration, which includes sales incentives provided to customers.
The Company’s camera sales contain multiple performance obligations that can include the following four separate obligations: a) a camera hardware component (which may be bundled with hardware accessories) and the embedded firmware essential to the functionality of the camera component delivered at the time of sale, b) a subscription and service, c) the implied right for the customer to receive post contract support after the initial sale (PCS), and d) the implicit right to the Company’s downloadable free apps and software solutions. The Company’s PCS includes the right to receive, on a when and if available basis, future unspecified firmware upgrades and features as well as bug fixes, and email, chat and telephone support.
The Company recognizes revenue from its sales arrangements when control of the promised goods or services are transferred to its customers, in an amount that reflects the amount of consideration expected to be received in exchange for the transferred goods or services. For the sale of hardware products, including related firmware and free software solutions, revenue is recognized when transfer of control occurs at a point in time, which generally is at the time the hardware product is shipped and collection is considered probable. For customers who purchase products directly from GoPro.com, the Company retains a portion of the risk of loss on these sales during transit, which are accounted for as fulfillment costs. For PCS, revenue is recognized ratably over 24 months, which represents the estimated service period based on historical experience. For subscriptions, revenue is recognized ratably over the subscription term, with any payments received in advance of services rendered recorded as deferred revenue.
For the Company’s camera sale arrangements with multiple performance obligations, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are based on observable price at which the Company separately sells its products, subscriptions, and services. If a standalone selling price is not directly observable, then the Company estimates the standalone selling prices considering market conditions and entity-specific factors. For example, the standalone selling price for PCS is determined based on a cost-plus approach, which incorporates the level of support provided to customers, estimated costs to provide support, and the amount of time and costs that are allocated to efforts to develop the undelivered elements.
The Company's standard terms and conditions of sale for non-web-based sales do not allow for product returns other than under warranty. However, the Company grants limited rights of return, primarily to certain large retailers. The Company reduces revenue and cost of sales for the estimated returns based on analyses of historical return trends by customer class and other factors. An estimated return liability along with a right to recover assets are recorded for future product returns. Return trends are influenced by product life cycles, new product introductions, market acceptance of products, product sell-through, the type of customer, seasonality and other factors. Return rates may fluctuate over time, but are sufficiently predictable to allow the Company to estimate expected future product returns.
The Company provides sales commissions to internal and external sales representatives which are earned in the period in which revenue is recognized. As a result, the Company expenses such costs as incurred.
Deferred revenue as of March 31, 2022 and December 31, 2021, includes amounts related to the Company’s subscription and service. The Company’s short-term and long-term deferred revenue balances totaled $49.4
million and $48.5 million as of March 31, 2022 and December 31, 2021, respectively. During the three months ended March 31, 2022 and 2021, the Company recognized $16.6 million and $10.2 million of revenue that was included in the deferred revenue balance as of December 31, 2021 and 2020, respectively
Revenue Recognition, Incentives Sales incentives. The Company offers sales incentives through various programs, including cooperative advertising, price protection, marketing development funds and other incentives. Sales incentives are considered to be variable consideration, which the Company estimates and records as a reduction to revenue at the date of sale. The Company estimates sales incentives based on historical experience, product sell-through and other factors.
Shipping and Handling Cost, Policy Shipping costs. Amounts billed to customers for shipping and handling are classified as revenue, and the Company’s related shipping and handling costs incurred are classified as cost of revenue.
Sales Taxes Sales taxes. Sales taxes collected from customers and remitted to respective governmental authorities are recorded as liabilities and are not included in revenue.
Advertising Cost Advertising costs. Advertising costs consist of costs associated with print, television and e-commerce media advertisements and are expensed as incurred. The Company incurs promotional expenses resulting from payments under event, resort and athlete sponsorship contracts. These sponsorship arrangements are considered to be executory contracts and, as such, the costs are expensed as performance under the contract is received. The costs associated with the preparation of sponsorship activities, including the supply of GoPro products, media team support, and activation fees are expensed as incurred. Prepayments made under sponsorship agreements are included in prepaid expenses or other long-term assets depending on the period to which the prepayment applies. Advertising costs were $35.8 million, $34.1 million and $67.3 million in 2022, 2021 and 2020, respectively.
Employee benefit plans Equity incentive plans. The Company has outstanding equity grants from its three stock-based employee compensation plans: the 2014 Equity Incentive Plan (2014 Plan), the 2010 Equity Incentive Plan (2010 Plan) and the 2014 Employee Stock Purchase Plan (ESPP). No new options or awards have been granted under the 2010 Plan since June 2014. Outstanding options and awards under the 2010 Plan continue to be subject to the terms and conditions of the 2010 Plan. Options granted under the 2014 Plan generally expire within ten years from the date of grant and generally vest over one to four years. Restricted stock units (RSUs) granted under the 2014 Plan generally vest over two to four years based upon continued service and are settled at vesting in shares of the Company’s Class A common stock. Performance stock units (PSUs) granted under the 2014 Plan generally vest over three years based upon continued service and the Company achieving certain financial and operating targets, and are settled at vesting in shares of the Company’s Class A common stock. The Company accounts for forfeitures of stock-based payment awards in the period they occur. The ESPP allows eligible employees to purchase shares of the Company’s Class A common stock through payroll deductions at a price equal to 85% of the lesser of the fair market value of the stock as of the first date or the ending date of each six-month offering period. For additional information regarding the Company’s equity incentive plans, refer to the 2021 Annual Report.
Stock options
A summary of the Company’s stock option activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average exercise price
Weighted-average remaining contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding at December 31, 20213,080 $9.18 5.92$8,735 
Granted321 8.70 
Exercised(20)5.93 
Forfeited/Cancelled(22)13.95 
Outstanding at March 31, 20223,359 $9.12 6.10$4,914 
Vested and expected to vest at March 31, 20223,359 $9.12 6.10$4,914 
Exercisable at March 31, 20222,273 $10.38 4.87$2,636 
The aggregate intrinsic value of the stock options outstanding as of March 31, 2022 represents the value of the Company’s closing stock price on March 31, 2022 in excess of the exercise price multiplied by the number of options outstanding.
Restricted stock units
A summary of the Company’s RSU activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20218,714 $6.52 
Granted2,988 9.01 
Vested(1,990)5.92 
Forfeited(238)7.17 
Non-vested shares at March 31, 20229,474 $7.42 
Performance stock units
A summary of the Company’s PSU activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20211,134 

$6.68 
Granted604 8.70 
Vested(352)7.09 
Forfeited— — 
Non-vested shares at March 31, 20221,386 $7.46 
Employee stock purchase plan. For the three months ended March 31, 2022 and 2021, the Company issued 0.3 million and 0.5 million shares under its ESPP, respectively, at weighted-average prices of $7.70 and $4.15, respectively.
Foreign Currency Transactions and Translations Policy Foreign currency. The U.S. dollar is the functional currency of the Company’s foreign subsidiaries. The Company remeasures monetary assets or liabilities denominated in currencies other than the U.S. dollar using exchange rates prevailing on the balance sheet date, and non-monetary assets and liabilities at historical rates. Foreign currency remeasurement and transaction gains and losses are included in other income (expense), net and have not been material for any periods presented.
Income Tax, Policy
Income taxes. The Company utilizes the asset and liability method for computing its income tax provision, under which deferred tax assets and liabilities are recognized for the expected future consequences of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates. Management makes estimates, assumptions and judgments to determine the Company’s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income in each tax jurisdiction and, to the extent the Company believes recovery is not likely, establishes a valuation allowance. In the period ended September 30, 2021, the Company assessed its deferred tax assets and based on the weight of available evidence, the Company concluded that it was more likely than not that its United States federal and state deferred tax assets would be realized. Therefore, in 2022 the Company released $1.4 million of valuation allowances, which resulted in a non-cash net benefit to earnings for the year ended December 31, 2021.
The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. Interest and penalties related to unrecognized tax benefits are recognized within income tax expense.
Segment information Segment information. The Company operates as one operating segment as it only reports financial information on an aggregate and consolidated basis to its Chief Executive Officer, who is the Company’s chief operating decision maker.
v3.22.1
Compensation Related Costs, Share Based Payments (Policies)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Share-based Payment Arrangement
The income tax benefit related to stock-based compensation expense was $2.2 million for the three months ended March 31, 2022. The income tax benefit related to stock-based compensation expense was zero for the three months ended March 31, 2021 due to a full valuation allowance on the Company’s United States net deferred tax assets. See Note 8, Income taxes, for additional details.
At March 31, 2022, total unearned stock-based compensation of $71.5 million related to stock options, RSUs, PSUs and ESPP shares is expected to be recognized over a weighted-average period of 2.13 years.
v3.22.1
Summary of business and significant accounting policies (Tables)
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of recent accounting pronouncements
Recent accounting standards
StandardDescriptionCompany’s date of adoption
Effect on the condensed consolidated financial statements or other significant matters
Standards that were adopted
Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)
ASU No. 2020-06

This standard simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. ASU 2020-06 (1) simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt: Debt with Conversion and Other Options, that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock, (2) revises the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification, and (3) revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share “EPS” for convertible instruments by using the if-converted method. Companies are allowed to adopt this standard via either a modified retrospective method of transition or a fully retrospective method of transition. Under the modified retrospective method, entities should apply the guidance to transactions outstanding as of the beginning of the fiscal year in which the amendments are adopted. Transactions that were settled (or expired) during prior reporting periods are unaffected. The cumulative effect of the change should be recognized as an adjustment to the opening balance of retained earnings at the date of adoption.
January 1, 2022
The Company adopted ASU 2020-06 using the modified retrospective transition method. As a result, prior period numbers were not restated.

Upon adoption, the Company recorded a net decrease to opening additional paid-in-capital of $78.2 million, with the impact primarily related to the reclassification of Senior Convertible Notes conversion feature’s fair value from additional paid-in-capital to short-term and long-term debt. Additionally, the Company recorded a decrease to opening accumulated deficit of approximately $47.1 million, with the impact related to the reclassification of the previously amortized debt discount and deferred financing costs. After adoption, the Company saw a reduction in its reported interest expense. In addition, the Company recorded a reversal of U.S. deferred tax liabilities (net) of $7.3 million, resulting in an additional corresponding decrease to opening accumulated deficit. The Company adopted the use of the if-converted method for calculating diluted earnings per share for its Senior Convertible Notes, which 1) resulted in an increase in weighted-average diluted shares outstanding, and 2) allowed for the adding back of the after-tax impact of interest charges for the period to the numerator.
Although there are several other new accounting standards issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its condensed consolidated financial statements.
v3.22.1
Fair value measurements (Tables)
 3 Months Ended
Mar. 31, 2022
Fair Value Disclosures [Abstract]  
Assets measured at fair value on recurring basis
The Company’s assets that are measured at fair value on a recurring basis within the fair value hierarchy are summarized as follows:
March 31, 2022December 31, 2021
(in thousands)Level 1Level 2TotalLevel 1Level 2Total
Cash equivalents (1):
Money market funds$201,425 $— $201,425 $183,304 $— $183,304 
Total cash equivalents$201,425 $— $201,425 $183,304 $— $183,304 
Marketable securities:
Commercial paper$— $66,609 $66,609 $— $72,323 $72,323 
Corporate debt securities— 34,840 34,840 — 41,108 41,108 
Government securities— 43,167 43,167 — 24,399 24,399 
Total marketable securities$— $144,616 $144,616 $— $137,830 $137,830 
(1)    Included in cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets. Cash balances were $103.9 million as of March 31, 2022 and $217.8 million as of December 31, 2021.
v3.22.1
Condensed consolidated financial statement details (Tables)
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Inventory
(in thousands)
March 31, 2022December 31, 2021
Components
$30,823 $10,761 
Finished goods
88,573 75,648 
Total inventory
$119,396 $86,409 
Property, Plant and Equipment
Property and equipment, net
(in thousands)
March 31, 2022December 31, 2021
Leasehold improvements$33,764 $33,764 
Production, engineering and other equipment46,264 45,641 
Tooling11,743 13,537 
Computers and software21,078 20,771 
Furniture and office equipment5,613 5,614 
Tradeshow equipment and other1,970 1,970 
Construction in progress31 480 
Gross property and equipment
120,463 121,777 
Less: Accumulated depreciation and amortization(103,169)(102,774)
Property and equipment, net
$17,294 $19,003 
Schedule of Other Assets
(in thousands)
March 31, 2022December 31, 2021
Point of purchase (POP) displays
$2,220 $2,509 
Long-term deferred tax assets
278,760 274,430 
Deposits and other
8,777 8,238 
Intangible assets, net1562
Other long-term assets$289,772 $285,239 
Schedule of Accrued Liabilities
Accrued expenses and other current liabilities
(in thousands)
March 31, 2022December 31, 2021
Accrued liabilities$29,028 $34,989 
Accrued sales incentives
27,485 34,117 
Employee related liabilities7,647 19,024 
Return liability
6,472 9,263 
Warranty liability
7,691 8,268 
Inventory received
4,633 7,169 
Customer deposits
2,330 2,760 
Purchase order commitments
2,238 1,369 
Other
9,067 11,613 
Accrued expenses and other current liabilities$96,591 $128,572 
Schedule of Product Warranty Liability
Product warranty
Three months ended March 31,
(in thousands)
20222021
Beginning balance
$8,842 $8,523 
Charged to cost of revenue
2,885 2,655 
Settlement of warranty claims
(3,715)(3,726)
Warranty liability
$8,012 $7,452 
v3.22.1
Employee benefit plans (Tables)
 3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
schedule of share-based compensation, Performance Stock Units Award Activity [Table Text Block]
A summary of the Company’s PSU activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20211,134 

$6.68 
Granted604 8.70 
Vested(352)7.09 
Forfeited— — 
Non-vested shares at March 31, 20221,386 $7.46 
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the Company’s stock option activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average exercise price
Weighted-average remaining contractual term (in years)
Aggregate intrinsic value (in thousands)
Outstanding at December 31, 20213,080 $9.18 5.92$8,735 
Granted321 8.70 
Exercised(20)5.93 
Forfeited/Cancelled(22)13.95 
Outstanding at March 31, 20223,359 $9.12 6.10$4,914 
Vested and expected to vest at March 31, 20223,359 $9.12 6.10$4,914 
Exercisable at March 31, 20222,273 $10.38 4.87$2,636 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of the Company’s RSU activity for the three months ended March 31, 2022 is as follows:
Shares
(in thousands)
Weighted-average grant date fair value
Non-vested shares at December 31, 20218,714 $6.52 
Granted2,988 9.01 
Vested(1,990)5.92 
Forfeited(238)7.17 
Non-vested shares at March 31, 20229,474 $7.42 
Allocation of Stock-based Compensation Expense The Company measures compensation expense for all stock-based payment awards based on the estimated fair values on the date of the grant. The fair value of stock options granted and ESPP issuance is estimated using the Black-Scholes option pricing model. The fair value of RSUs and PSUs are determined using the Company’s closing stock price on the date of grant. There have been no significant changes in the Company’s valuation assumptions from those disclosed in its 2021 Annual Report.
The following table summarizes stock-based compensation expense included in the Condensed Consolidated Statements of Operations:
Three months ended March 31,
(in thousands)
20222021
Cost of revenue
$447 $429 
Research and development
4,158 4,136 
Sales and marketing
2,123 1,865 
General and administrative
3,108 2,439 
Total stock-based compensation expense
$9,836 $8,869 
Class of Treasury Stock
Three months ended March 31, 2022
(in thousands, except per share data)
Shares repurchased1,120 
Average price per share$8.93 
Value of shares repurchased$10,000 
v3.22.1
Net loss per share (Tables)
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Net Income per Share, Basic and Diluted
The following table presents the calculations of basic and diluted net income (loss) per share:
Three months ended March 31,
(in thousands, except per share data)
20222021
Numerator:
Net income (loss) - Basic$5,685 $(10,168)
Interest on convertible notes, income tax effected1,521 — 
Net income (loss) - Diluted7,206 (10,168)
Denominator:
Weighted-average common shares - basic for Class A and Class B common stock156,864 152,181 
Effect of dilutive securities31,873 — 
Weighted-average common shares - diluted for Class A and Class B common stock188,737 152,181 
Net income (loss) per share
Basic$0.04 $(0.07)
Diluted$0.04 $(0.07)
Schedule of Antidilutive Securities Excluded from Computation of Net Income per Share
The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:
Three months ended March 31,
(in thousands)
20222021
Stock-based awards4,256 15,750 
Shares related to convertible senior notes— 194 
Total anti-dilutive securities4,256 15,944 
v3.22.1
Income taxes (Tables)
 3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit)
The Company’s tax provision and the resulting effective tax rate for interim periods is determined based upon its estimated annual effective tax rate, adjusted for the effect of discrete items arising in that quarter. The Company also excludes jurisdictions with a projected loss for the year (or year-to-date loss) where the Company cannot or does not expect to recognize a tax benefit from its estimated annual effective tax rate. The impact of such inclusions could result in a higher or lower effective tax rate during a particular quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual tax rate changes, a cumulative adjustment is made in that quarter.
Three months ended March 31,
(dollars in thousands)20222021
Income tax expense (benefit)$(51)$1,219 
v3.22.1
Commitments, contingencies and guarantees (Tables)
 3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Components of Lease Expense [Text Block]
The components of net lease cost, which were recorded in operating expenses, were as follows:
Three months ended March 31,
(in thousands)20222021
Operating lease cost (1)
$2,850 $3,096 
Sublease income(731)(133)
Net lease cost$2,119 $2,963 
(1)    Operating lease cost includes variable lease costs, which are immaterial.
Supplemental cash flow information related to leases was as follows:
Three months ended March 31,
(in thousands)20222021
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases$3,777 $3,690 
Right-of-use assets obtained in exchange for operating lease liabilities— 821 

Supplemental balance sheet information related to leases was as follows:
March 31, 2022December 31, 2021
Weighted-average remaining lease term (in years) - operating leases4.434.64
Weighted-average discount rate - operating leases6.1%6.0%
Schedule of Maturities of Lease Liabilities [Text Block]
As of March 31, 2022, maturities of operating lease liabilities were as follows:
(in thousands)
March 31, 2022
2022 (remaining 9 months)9,205 
202312,758 
202411,748 
202511,477 
202611,710 
Thereafter974 
Total lease payments57,872 
Less: Imputed interest(7,803)
Present value of lease liabilities$50,069 
v3.22.1
Concentrations of risk and geographic information (Tables)
 3 Months Ended
Mar. 31, 2022
Concentration Risk [Line Items]  
Schedule of Accounts, Notes, Loans and Financing Receivable
The following table summarizes the Company’s accounts receivables sold, without recourse, and factoring fees paid:
Three months ended March 31,
(in thousands)
20222021
Accounts receivable sold$23,949 $30,734 
Factoring fees53 207 
Schedule of Revenue by Geographic Region
Revenue by geographic region was as follows:
Three months ended March 31,
(in thousands)
20222021
Americas
$102,583 $106,638 
Europe, Middle East and Africa (EMEA)
61,531 49,803 
Asia and Pacific (APAC)
52,591 47,239 
Total revenue
$216,705 $203,680 
Accounts Receivable [Member]  
Concentration Risk [Line Items]  
Schedules of Customer Concentration by Risk Factor
Customers who represented 10% or more of the Company’s net accounts receivable balance were as follows:
March 31, 2022December 31, 2021
Customer A17%18%
Customer B19%30%
Customer C13%*
Sales Revenue [Member]  
Concentration Risk [Line Items]  
Schedules of Customer Concentration by Risk Factor
Third-party customers who represented 10% or more of the Company’s total revenue were as follows:
Three months ended March 31,
20222021
Customer A*11%
* Less than 10% of total revenue for the period indicated.
v3.22.1
Summary of business and significant accounting policies (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Jan. 01, 2022
Dec. 31, 2021
Nov. 24, 2020
Apr. 12, 2017
Property, Plant and Equipment [Line Items]              
Restricted Cash $ 0       $ 0    
Allowance for Doubtful Other Receivables, Current 700       700    
Operating Lease, Impairment Loss   $ 12,500          
Contract with Customer, Liability 49,400       48,500    
Deferred Revenue, Revenue Recognized 16,600 10,200          
Advertising Expense 35,800 $ 34,100 $ 67,300        
Accumulated deficit $ (219,275)     $ 47,100 $ (279,345)    
Product Warranty Liability [Line Items]              
Warranty Period 12 months            
Convertible Senior Notes due 2022 [Member]              
Property, Plant and Equipment [Line Items]              
Interest rate             3.50%
Debt Instrument             $ 175,000
Convertible Senior Notes due 2025 [Member]              
Property, Plant and Equipment [Line Items]              
Interest rate           1.25%  
Debt Instrument           $ 143,800  
Europe [Member]              
Product Warranty Liability [Line Items]              
Warranty Period 24 months            
v3.22.1
Fair value measurements (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Nov. 24, 2020
Apr. 12, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash $ 103,900 $ 217,800    
Marketable securities 144,616 137,830    
Restricted Cash 0 0    
Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 201,425 183,304    
Marketable securities 144,616 137,830    
Fair Value, Recurring [Member] | Money Market Funds [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 201,425 183,304    
Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 201,425 183,304    
Marketable securities 0 0    
Fair Value, Recurring [Member] | Level 1 [Member] | Money Market Funds [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 201,425 183,304    
Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 0 0    
Marketable securities 144,616 137,830    
Fair Value, Recurring [Member] | Level 2 [Member] | Money Market Funds [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Cash and Cash Equivalents 0 0    
Convertible Senior Notes due 2022 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Debt Instrument       $ 175,000
Convertible Senior Notes due 2022 [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair value of convertible senior notes 125,000 132,400    
Convertible Senior Notes due 2025 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Debt Instrument     $ 143,800  
Convertible Senior Notes due 2025 [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair value of convertible senior notes 166,100 189,000    
Corporate Debt Securities [Member] | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 34,840 41,108    
Corporate Debt Securities [Member] | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
Corporate Debt Securities [Member] | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 34,840 41,108    
Commercial Paper | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 66,609 72,323    
Commercial Paper | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
Commercial Paper | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 66,609 72,323    
US Government Debt Securities [Member] | Fair Value, Recurring [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 43,167 24,399    
US Government Debt Securities [Member] | Fair Value, Recurring [Member] | Level 1 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities 0 0    
US Government Debt Securities [Member] | Fair Value, Recurring [Member] | Level 2 [Member]        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Marketable securities $ 43,167 $ 24,399    
v3.22.1
Condensed consolidated financial statement details - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Cash and Cash Equivalents [Line Items]    
Cash $ 103,900 $ 217,800
Cash and cash equivalents $ 305,319 $ 401,087
v3.22.1
Condensed consolidated financial statement details - Inventory (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Components $ 30,823 $ 10,761
Finished goods 88,573 75,648
Total inventory $ 119,396 $ 86,409
v3.22.1
Condensed consolidated financial statement details - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2021
Property, Plant and Equipment [Line Items]        
Gross property and equipment $ 120,463     $ 121,777
Less: Accumulated depreciation and amortization (103,169)     (102,774)
Property and equipment, net 17,294     19,003
Depreciation 9,800 $ 9,800 $ 14,500  
Leasehold Improvements [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment 33,764     33,764
Production, engineering and other equipment [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment 46,264     45,641
Tooling [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment 11,743     13,537
Computers and software [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment 21,078     20,771
Furniture and office equipment [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment 5,613     5,614
Tradeshow Equipment and other [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment 1,970     1,970
Construction in Progress [Member]        
Property, Plant and Equipment [Line Items]        
Gross property and equipment $ 31     $ 480
v3.22.1
Condensed consolidated financial statement details - Intangible Assets and Goodwill (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Finite-Lived Intangible Assets, Net [Abstract]      
Finite-Lived Intangible Assets, Gross $ 51,066   $ 51,066
Finite-Lived Intangible Assets, Accumulated Amortization (51,066)   (51,019)
Finite-Lived Intangible Assets, Net, Total 0   47
Intangible Assets, Gross (Excluding Goodwill) 51,081   51,081
Intangible assets, net 15   62
Indefinite-lived Intangible Assets [Roll Forward]      
Amortization of intangible assets 100 $ 700  
Goodwill 146,459   146,459
Indefinite-Lived Trademarks $ 15   $ 15
v3.22.1
Condensed consolidated financial statement details - Future Amortization (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Finite-Lived Intangible Assets, Net, Total $ 0 $ 47
v3.22.1
Condensed consolidated financial statement details - Goodwill (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Goodwill $ 146,459 $ 146,459
v3.22.1
Condensed consolidated financial statement details - Other Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
POP Displays $ 2,220     $ 2,509
Deferred Income Tax Assets, Net 278,760     274,430
Deposits and other 8,777     8,238
Other long-term assets 289,772     285,239
Amortization of intangible assets 100 $ 700    
Amortization 2,800 $ 2,800 $ 4,200  
Intangible Assets, Net (Excluding Goodwill) $ 15     $ 62
v3.22.1
Condensed consolidated financial statement details - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Employee related liabilities $ 7,647 $ 19,024
Accrued sales incentives 27,485 34,117
Other Accounts Payable and Accrued Liabilities 29,028 34,989
Customer Refund Liability, Current 6,472 9,263
Warranty liability 7,691 8,268
Customer deposits 2,330 2,760
Purchase Commitment, Remaining Minimum Amount Committed 2,238 1,369
Inventory received 4,633 7,169
Other 9,067 11,613
Accrued expenses and other current liabilities $ 96,591 $ 128,572
v3.22.1
Condensed consolidated financial statement details - Product Warranty (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Beginning balances $ 8,842 $ 8,523  
Charged to cost of revenue 2,885 2,655  
Settlements of warranty claims (3,715) (3,726)  
Ending balances 8,012 $ 7,452  
Warranty liability 7,691   $ 8,268
Product Warranty Accrual, Noncurrent $ 300   $ 500
v3.22.1
Financing Arrangements (Details)
$ / shares in Units, shares in Thousands
 3 Months Ended
Jan. 21, 2021
USD ($)
Nov. 24, 2020
USD ($)
$ / shares
Apr. 12, 2017
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Mar. 31, 2021
USD ($)
shares
Jan. 01, 2022
USD ($)
Apr. 01, 2021
shares
Jan. 22, 2021
USD ($)
Oct. 22, 2020
shares
Line of Credit Facility [Line Items]                    
Long-term debt       $ 140,304,000 $ 111,289,000          
Amortization of Debt Discount (Premium)       $ 0   $ 3,433,000        
Payments for Repurchase of Equity, Prepaid Forward     $ 78,000,000              
Treasury Shares Acquired, Estimated, Prepaid Forward | shares           9,200        
Operating Lease, Impairment Loss           $ 12,500,000        
Own-share Lending Arrangement, Shares, Issued | shares     9,200              
SharesPurchasedUnderPrepaidForward | shares               400   8,800
Debt Instrument, Covenant Compliance, Asset Coverage Ratio       1.50            
Adjustments to Additional Paid in Capital, Capped Call Option, Issuance Costs         (10,200,000)          
Option Indexed To Issuers Equity, cap price   $ 12.0925                
Payments to repurchase convertible debt         50,000,000          
Interest Paid, Including Capitalized Interest, Operating and Investing Activities         200,000          
Short-term Debt       $ 124,900,000            
Letters of Credit Outstanding, Amount       5.2            
Convertible Senior Notes due 2022 [Member]                    
Line of Credit Facility [Line Items]                    
Debt Instrument, Unamortized Discount       0            
Convertible Debt Principal Amount Conversion       125,000,000            
Amortization of Debt Issuance Costs       200,000            
Amortization of Debt Discount (Premium)       0            
Short-term Debt | Convertible Senior Notes due 2022 [Member]                    
Line of Credit Facility [Line Items]                    
Debt Issuance Costs, Net       $ 100,000            
Convertible Senior Notes due 2025 [Member] | Private Placement [Member]                    
Line of Credit Facility [Line Items]                    
Debt Instrument   $ 125,000,000                
2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Credit agreement, current borrowing capacity                 $ 50,000,000  
Minimum Fixed Charge Coverage Ratio, minimum balance $ 10,000,000                  
Line of Credit Facility, Unused Capacity, Minimum Liquidity Requirement, Amount 55,000,000                  
Line of Credit Facility, Unused Capacity, Qualified Cash $ 40,000,000                  
Convertible Senior Notes due 2022 [Member]                    
Line of Credit Facility [Line Items]                    
Debt Instrument     $ 175,000,000              
Long-term Debt, Percentage Bearing Fixed Interest, Amount     $ 128,300,000       $ 2,300,000      
Debt Instrument, Unamortized Discount         2,400,000          
Interest rate     3.50%              
Debt Instrument, Convertible, Conversion Ratio     94.0071              
Convertible Debt Principal Amount Conversion     $ 1,000   125,000,000          
Debt Instrument, Convertible, Conversion Price | $ / shares     $ 10.64              
Convertible debt, equity portion     $ 46,700,000              
Effective rate   2.40% 10.50%              
Debt Issuance Costs, Net     $ 5,700,000              
Percentage of conversion price of notes       130.00%            
Percentage of trading price of notes       98.00%            
Long-term debt         122,400,000          
Interest Expense, Debt       $ 1,100,000   1,100,000        
Amortization of Debt Issuance Costs           100,000        
Amortization of Debt Discount (Premium)           1,900,000        
Gain (Loss) on Extinguishment of Debt         5,400,000          
Debt Instrument, Repurchase Amount   $ 56,200,000                
Debt Instrument, Repurchased Face Amount   45,200,000                
Convertible Senior Notes due 2022 [Member] | Long-term Debt [Member]                    
Line of Credit Facility [Line Items]                    
Debt Issuance Costs, Gross     4,200,000              
Debt Issuance Costs, Net         200,000          
proceedsfromconvertibledebtamountallocatedtodebtcomponent         50,600,000          
Convertible Senior Notes due 2022 [Member] | Additional Paid-in Capital [Member]                    
Line of Credit Facility [Line Items]                    
Debt Issuance Costs, Gross     $ 1,500,000              
proceedsfromconvertibledebtamountallocatedtoequitycomponent         5,400,000          
Convertible Senior Notes due 2025 [Member]                    
Line of Credit Facility [Line Items]                    
Debt Instrument   143,800,000                
Long-term Debt, Percentage Bearing Fixed Interest, Amount   $ 106,900,000         $ 28,800,000      
Debt Instrument, Unamortized Discount       0 29,700,000          
Interest rate   1.25%                
Debt Instrument, Convertible, Conversion Ratio   107.1984                
Convertible Debt Principal Amount Conversion   $ 1,000   $ 143,800,000 143,800,000          
Debt Instrument, Convertible, Conversion Price | $ / shares   $ 9.3285                
Convertible debt, equity portion   $ 36,900,000                
Effective rate   7.50%                
Debt Issuance Costs, Net   $ 4,700,000                
Percentage of conversion price of notes       130.00%            
Percentage of trading price of notes       98.00%            
Long-term debt       $ 140,300,000 111,300,000          
Interest Expense, Debt       400,000   400,000        
Amortization of Debt Issuance Costs       200,000   200,000        
Amortization of Debt Discount (Premium)       0   $ 1,600,000        
Convertible Senior Notes due 2025 [Member] | Long-term Debt [Member]                    
Line of Credit Facility [Line Items]                    
Debt Issuance Costs, Gross   3,500,000                
Debt Issuance Costs, Net       $ 3,400,000 $ 2,700,000          
Convertible Senior Notes due 2025 [Member] | Additional Paid-in Capital [Member]                    
Line of Credit Facility [Line Items]                    
Debt Issuance Costs, Gross   1,200,000                
Convertible Senior Notes due 2025 [Member] | Over-Allotment Option [Member]                    
Line of Credit Facility [Line Items]                    
Debt Instrument   $ 18,800,000                
Minimum [Member] | 2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Unused Capacity, Commitment Fee Percentage 0.375%                  
Maximum [Member] | 2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Unused Capacity, Commitment Fee Percentage 0.50%                  
London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member] | 2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Basis Spread on Variable Rate 1.50%                  
London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member] | 2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Basis Spread on Variable Rate 2.00%                  
Base Rate [Member] | Minimum [Member] | 2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Basis Spread on Variable Rate 0.50%                  
Base Rate [Member] | Maximum [Member] | 2021 Credit Facility [Member]                    
Line of Credit Facility [Line Items]                    
Basis Spread on Variable Rate 1.00%                  
v3.22.1
Stockholders' equity (Details) - USD ($)
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2021
Dec. 31, 2020
Class of Stock [Line Items]        
Stock options outstanding (shares) 3,359,000 3,080,000    
Stockholders' Equity Attributable to Parent $ 592,786,000 $ 615,914,000 $ 211,471,000 $ 216,018,000
Stock Repurchase Program, Authorized Amount 100      
Stock Repurchase Program, Remaining Authorized Repurchase Amount $ 90      
Treasury Stock, Shares, Acquired 1,120      
Treasury Stock Acquired, Average Cost Per Share $ 8.93      
Stock Repurchased During Period, Value $ 10,000,000      
Treasury Stock [Member]        
Class of Stock [Line Items]        
Stockholders' Equity Attributable to Parent $ (123,613,000) $ (113,613,000) $ (113,613,000) $ (113,613,000)
Common Class A [Member]        
Class of Stock [Line Items]        
Common stock authorized (shares) 500,000,000 500,000,000    
Common stock outstanding (shares) 130,787,000 129,815,000    
Common Stock, Voting Rights, Number 1      
Common Stock, Shares, Issued 130,787,000 129,815,000    
Common Class B [Member]        
Class of Stock [Line Items]        
Common stock authorized (shares) 150,000,000 150,000,000    
Common stock outstanding (shares) 26,458,000 26,659,000    
Common Stock, Voting Rights, Number 10      
Common Stock, Shares, Issued 26,458,000 26,659,000    
Restricted Stock Units (RSUs) [Member]        
Class of Stock [Line Items]        
Restricted stock units outstanding (shares) 9,474,000 8,714,000    
Performance Shares [Member]        
Class of Stock [Line Items]        
Restricted stock units outstanding (shares) 1,386,000 1,134,000    
v3.22.1
Employee benefit plans - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Allocated share-based compensation expense $ 9,836 $ 8,869
ESPP stock issued during period (shares) 300,000 500,000
ESPP weighted average purchase price of shares purchased (usd per share) $ 7.70 $ 4.15
Unearned stock-based compensation, expected recognition period 2 years 1 month 17 days  
Stock Repurchased During Period, Shares 1,120,000  
Treasury Stock Acquired, Average Cost Per Share $ 8.93  
Stock Repurchased During Period, Value $ 10,000  
RSUs [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares granted (shares) 2,988,000  
Weighted average price of shares granted (usd per share) $ 9.01  
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Shares granted (shares) 604,000  
Weighted average price of shares granted (usd per share) $ 8.70  
Employee Stock Purchase Plan Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Purchase Price of Common Stock, Percent 85.00%  
Stock Options, ESPP and Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unearned stock-based compensation costs $ 71,500  
2014 Equity Incentive Plans [Member] | Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Expiration Period 10 years  
2014 Equity Incentive Plans [Member] | Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award Vesting Period 3 years  
2014 Equity Incentive Plans [Member] | Minimum [Member] | Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award Vesting Period 1 year  
2014 Equity Incentive Plans [Member] | Minimum [Member] | RSUs [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award Vesting Period 2 years  
2014 Equity Incentive Plans [Member] | Maximum [Member] | Stock Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award Vesting Period 4 years  
2014 Equity Incentive Plans [Member] | Maximum [Member] | RSUs [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Award Vesting Period 4 years  
v3.22.1
Employee benefit plans - Stock Option Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Shares (in thousands)    
Outstanding at beginning of period (shares) 3,080  
Granted (shares) 321  
Exercised (shares) (20)  
Forfeited/Cancelled (shares) (22)  
Outstanding at end of period (shares) 3,359 3,080
Weighted-average exercise price    
Outstanding at beginning of period (in dollars per share) $ 9.18  
Granted (usd per share) 8.70  
Exercised (usd per share) 5.93  
Outstanding at end of period (in dollars per share) $ 9.12 $ 9.18
Aggregate intrinsic value (in thousands) $ 4,914 $ 8,735,000
Vested and Expected to Vest (shares) 3,359  
Vested and Expected to Vest - Weighted Average Exercise Price (in dollars per share) $ 9.12  
Vested and Expected to Vest- Weighted Average Remaining Contractual Term 6 years 1 month 6 days  
Vested and Expected to Vest - Aggregate Intrinsic Value $ 4,914  
Exercisable (shares) 2,273  
Exercisable - Weighted average exercise price (in dollars per share) $ 10.38  
Exercisable - Weighted Average Remaining Contractual Term 4 years 10 months 13 days  
Exercisable - Aggregate intrinsic value $ 2,636  
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price $ 13.95  
Stock Repurchase Program, Remaining Authorized Repurchase Amount $ 90  
Stock Repurchase Program, Authorized Amount $ 100  
Equity, Class of Treasury Stock [Line Items]    
Weighted Average Remaining Contractual Term (in years) 6 years 1 month 6 days 5 years 11 months 1 day
v3.22.1
Employee benefit plans - Restricted Stock Units Activity (Details)
shares in Thousands
 3 Months Ended
Mar. 31, 2022
$ / shares
shares
RSUs [Member]  
Shares (in thousands)  
Non-vested shares at beginning of period (shares) | shares 8,714
Granted (shares) | shares 2,988
Vested (shares) | shares (1,990)
Forfeited (shares) | shares (238)
Non-vested shares at end of period (shares) | shares 9,474
Weighted-average grant date fair value  
Non-vested shares at beginning of period (in dollars per share) | $ / shares $ 6.52
Weighted average price of shares granted (usd per share) | $ / shares 9.01
Weighted average price of shares vested (usd per share) | $ / shares 5.92
Weighted average price of shares forfeited (usd per share) | $ / shares 7.17
Non-vested shares at end of period (in dollars per share) | $ / shares $ 7.42
Performance Shares [Member]  
Shares (in thousands)  
Non-vested shares at beginning of period (shares) | shares 1,134
Granted (shares) | shares 604
Vested (shares) | shares (352)
Forfeited (shares) | shares 0
Non-vested shares at end of period (shares) | shares 1,386
Weighted-average grant date fair value  
Non-vested shares at beginning of period (in dollars per share) | $ / shares $ 6.68
Weighted average price of shares granted (usd per share) | $ / shares 8.70
Weighted average price of shares vested (usd per share) | $ / shares 7.09
Weighted average price of shares forfeited (usd per share) | $ / shares 0
Non-vested shares at end of period (in dollars per share) | $ / shares $ 7.46
v3.22.1
Employee benefit plans - Allocation of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 9,836 $ 8,869
Cost of Revenue [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 447 429
Research and Development [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 4,158 4,136
Selling and Marketing Expense [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense 2,123 1,865
General and Administrative [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total stock-based compensation expense $ 3,108 $ 2,439
v3.22.1
Employee benefit plans Performance Stock Units activity (Details) - $ / shares
shares in Thousands
 3 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Performance Shares [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock units outstanding (shares) 1,386 1,134
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 7.46 $ 6.68
Granted (shares) 604  
Weighted average price of shares granted (usd per share) $ 8.70  
Vested (shares) (352)  
Weighted average price of shares vested (usd per share) $ 7.09  
Forfeited (shares) 0  
Weighted average price of shares forfeited (usd per share) $ 0  
Restricted Stock Units (RSUs) [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Restricted stock units outstanding (shares) 9,474 8,714
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 7.42 $ 6.52
Granted (shares) 2,988  
Weighted average price of shares granted (usd per share) $ 9.01  
Vested (shares) (1,990)  
Weighted average price of shares vested (usd per share) $ 5.92  
Forfeited (shares) (238)  
Weighted average price of shares forfeited (usd per share) $ 7.17  
v3.22.1
Net loss per share Additional Information (Details)
 3 Months Ended
Nov. 24, 2020
USD ($)
shares
$ / shares
Apr. 12, 2017
USD ($)
shares
$ / shares
Mar. 31, 2022
shares
Mar. 31, 2021
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Treasury Shares Acquired, Estimated, Prepaid Forward       9,200,000
Option Indexed to Issuer's Equity, Strike Price | $ / shares $ 12.0925      
Option Indexed To Issuers Equity, cap price | $ $ 12.0925      
Common Class A [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common Stock, Voting Rights, Number     1  
Conversion of Stock, Shares Issued     1  
Common Class B [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common Stock, Voting Rights, Number     10  
Convertible Senior Notes due 2022 [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Debt Instrument | $   $ 175,000,000    
Interest rate   3.50%    
Maximum number of shares issuable upon conversion of the notes   20,600,000    
Debt Instrument, Convertible, Conversion Price | $ / shares   $ 10.64    
Convertible Senior Notes due 2025 [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Debt Instrument | $ $ 143,800,000      
Interest rate 1.25%      
Maximum number of shares issuable upon conversion of the notes 20,800,000      
Debt Instrument, Convertible, Conversion Price | $ / shares $ 9.3285      
v3.22.1
Net loss per share - Basic and Diluted Net Income per Share Attributable to Common Stockholders (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Apr. 12, 2017
Earnings Per Share [Abstract]      
Treasury Shares Acquired, Estimated, Prepaid Forward   9,200  
Numerator:      
Net income (loss) $ 5,685 $ (10,168)  
Interest on Convertible Debt, Net of Tax 1,521 0  
Net Income (Loss) Attributable to Parent, Diluted $ 7,206 $ (10,168)  
Denominator:      
Weighted Average Number of Shares Outstanding, Basic 156,864 152,181  
Weighted Average Number Diluted Shares Outstanding Adjustment 31,873 0  
Own-share Lending Arrangement, Shares, Issued     9,200
Treasury Shares Acquired, Estimated, Prepaid Forward   9,200  
Earnings Per Share, Diluted $ 0.04 $ (0.07)  
Weighted Average Number of Shares Outstanding, Diluted 188,737 152,181  
v3.22.1
Net loss per share - Antidilutive Securities Excluded from Computation of Net Income per Share (Details) - shares
shares in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Earnings Per Share [Abstract]    
Antidilutive securities excluded from computation of earnings per share (shares) 4,256 15,944
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (shares) 4,256 15,944
Convertible Debt Securities    
Earnings Per Share [Abstract]    
Antidilutive securities excluded from computation of earnings per share (shares) 0 194
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share (shares) 0 194
Share-based Payment Arrangement    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Earnings Per Share, Potentially Dilutive Securities 4,256 15,750
v3.22.1
Income taxes - Income Tax Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax (benefit) expense $ (51) $ 1,219
Current Foreign Tax Expense (Benefit) $ 1,400 1,300
Other Tax Expense (Benefit)   200
Income Tax Effects Allocated Directly to Equity, Other   $ 1,800
v3.22.1
Income taxes - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Operating Loss Carryforwards [Line Items]      
Other Tax Expense (Benefit)   $ 200  
Income tax (benefit) expense $ (51) 1,219  
Loss before income taxes 5,634 (8,949)  
Current Foreign Tax Expense (Benefit) 1,400 1,300  
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 1,400 $ 2,000  
Unrecognized Tax Benefits 21,800   $ 21,300
Unrecognized Tax Benefits that Would Impact Effective Tax Rate $ 7,900    
v3.22.1
Income taxes - Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Deferred tax assets:    
Deferred Tax Assets, Net, Total $ 278,760 $ 274,430
v3.22.1
Income taxes - Reconciliation (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax (benefit) expense $ (51) $ 1,219
v3.22.1
Commitments, contingencies and guarantees (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Long-term Purchase Commitment [Line Items]      
Operating Lease, Cost $ 2,850 $ 3,096  
Operating Lease, Payments 3,777 3,690  
Finance Lease, Liability, to be Paid, Year One 9,205    
Finance Lease, Liability, to be Paid, Year Two 12,758    
Finance Lease, Liability, to be Paid, Year Three 11,748    
Finance Lease, Liability, to be Paid, Year Four 11,477    
Finance Lease, Liability, to be Paid, Year Five 11,710    
Lessee, Operating Lease, Liability, Payments, Due after Year Five 974    
Lessee, Operating Lease, Liability, Payments, Due (57,872)    
us-gaap_Lessee Operating Lease Liability Undiscounted Excess Amount (7,803)    
Operating Lease, Liability 50,069    
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability $ 0 821  
Operating Lease, Weighted Average Remaining Lease Term 4 years 5 months 4 days   4 years 7 months 20 days
Operating Lease, Weighted Average Discount Rate, Percent 6.10%   6.00%
Sublease Income $ (731) (133)  
Operating Lease, Impairment Loss   12,500  
Lease, Cost 2,119 $ 2,963  
Other Commitments [Line Items]      
Other Commitment $ 348,500    
v3.22.1
Concentrations of risk and geographic information - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Revenue, Major Customer [Line Items]      
Revenue $ 216,705 $ 203,680  
United States [Member]      
Revenue, Major Customer [Line Items]      
Revenue 85,200 $ 93,300  
Outside the United States [Member]      
Revenue, Major Customer [Line Items]      
Long-lived assets $ 5,300   $ 5,700
v3.22.1
Concentrations of risk and geographic information - Schedule of Customer Concentration by Risk Factor (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Jun. 30, 2021
Concentration Risk [Line Items]      
Accounts receivable sold $ 23,949 $ 30,734  
Factoring fees $ 53 $ 207  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer A [Member]      
Concentration Risk [Line Items]      
Concentration risk 17.00%   18.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer B [Member]      
Concentration Risk [Line Items]      
Concentration risk 19.00%   30.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer C [Member]      
Concentration Risk [Line Items]      
Concentration risk 13.00%    
Customer Concentration Risk [Member] | Sales Revenue [Member] | Customer A [Member]      
Concentration Risk [Line Items]      
Concentration risk   11.00%  
v3.22.1
Concentrations of risk and geographic information - Schedule of Revenue by Geographic Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Segment Reporting Information [Line Items]    
Revenue $ 216,705 $ 203,680
United States [Member]    
Segment Reporting Information [Line Items]    
Revenue 85,200 93,300
Americas [Member]    
Segment Reporting Information [Line Items]    
Revenue 102,583 106,638
Europe, Middle East and Africa [Member]    
Segment Reporting Information [Line Items]    
Revenue 61,531 49,803
Asia and Pacific Area Countries [Member]    
Segment Reporting Information [Line Items]    
Revenue $ 52,591 $ 47,239
v3.22.1
Restructuring charges - Restructuring Costs (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2021
USD ($)
Restructuring Cost and Reserve [Line Items]  
Operating Lease, Impairment Loss $ 12.5
v3.22.1
Restructuring charges - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2021
USD ($)
Restructuring Cost and Reserve [Line Items]  
Operating Lease, Impairment Loss $ 12.5
v3.22.1
Subsequent Events (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Subsequent Event [Line Items]      
Sublease Income $ 731 $ 133  
Operating Lease, Weighted Average Discount Rate, Percent 6.10%   6.00%